Processing 00000000.tx.1: Parkinson's disease -synuclein mutations exhibit defective axonal transport in cultured neurons Anirban R. 

Phrase: "Parkinson's disease -synuclein mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "defective axonal transport in cultured neurons Anirban R."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0004462:Axonal Transport [Cell Function]
   750   C0178766:neuron transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C1317949:Transport [Manufactured Object]
   744   C3495449:transport [Medical Device]
Processing 00000000.tx.2: Saha1,*, Josephine Hill1,*, Michelle A. 

Phrase: "Saha1,"

Phrase: "*,"

Phrase: "Josephine Hill1,"

Phrase: "*,"

Phrase: "Michelle A."
Processing 00000000.tx.3: Utton1, Ayodeji A. 

Phrase: "Utton1,"

Phrase: "Ayodeji A."
Processing 00000000.tx.4: Asuni1, Steven Ackerley1, Andrew J. 

Phrase: "Asuni1,"

Phrase: "Steven Ackerley1,"

Phrase: "Andrew J."
Processing 00000000.tx.5: Grierson1, Christopher C. 

Phrase: "Grierson1,"

Phrase: "Christopher C."
Processing 00000000.tx.6: Miller1, Alun M. 

Phrase: "Miller1,"

Phrase: "Alun M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.7: Davies2, Vladimir L. 

Phrase: "Davies2,"

Phrase: "Vladimir L."
Processing 00000000.tx.8: Buchman2, Brian H. 

Phrase: "Buchman2,"

Phrase: "Brian H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.9: Anderton1 and Diane P. 

Phrase: "Anderton1"

Phrase: "and"

Phrase: "Diane P."
Processing 00000000.tx.10: Hanger1, 1 Department of Neuroscience, PO Box 38, Institute of Psychiatry, King's College London, De Crespigny Park, London, SE5 8AF, UK 2 Department of Preclinical Veterinary Sciences, Royal (Dick) School of Veterinary Studies, Edinburgh, EH9 1QH, UK Author for correspondence (e-mail: d.hanger{at}iop.kcl.ac.uk ) Accepted 4 November 2003  Summary Top Summary Introduction Materials and Methods Results Discussion References  -Synuclein is a major protein constituent of Lewy bodies and mutations in -synuclein cause familial autosomal dominant Parkinson's disease. 

Phrase: "Hanger1,"

Phrase: "1 Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1704729:Department [Organization]

Phrase: "PO Box 38,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179400:Box [Manufactured Object]
   827   C0442027:PO [Spatial Concept]
   827   C1533124:Box [Medical Device]

Phrase: "Institute of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021622:institute [Organization]
   790   C1272753:Institute [Idea or Concept]

Phrase: "King's College London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023973:London [Geographic Area]

Phrase: "De Crespigny Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0562547:Park [Manufactured Object]
   827   C3160718:PARK [Disease or Syndrome]

Phrase: "London,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023973:London [Geographic Area]

Phrase: "SE5 8AF,"

Phrase: "UK 2 Department of Preclinical Veterinary Sciences,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1704729:Department [Organization]

Phrase: "Royal"

Phrase: "(Dick"

Phrase: ")"

Phrase: "School of Veterinary Studies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0036383:Veterinary School [Health Care Related Organization,Manufactured Object]
   770   C0036375:School [Manufactured Object,Organization]

Phrase: "Edinburgh,"

Phrase: "EH9 1QH,"

Phrase: "UK Author for correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0221193:Author [Professional or Occupational Group]

Phrase: "(e-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "d."

Phrase: "hanger{at}iop.kcl.ac.uk"

Phrase: ")"

Phrase: "Accepted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1272684:Accepted [Qualitative Concept]
  1000   C1548435:Accepted [Idea or Concept]
   966 E C1548601:Accept [Idea or Concept]

Phrase: "4 November 2003  Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References  -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a major protein constituent of Lewy bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0729650:constituent [Substance]

Phrase: "and"

Phrase: "mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "familial autosomal dominant Parkinson's disease."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   937   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]
   897   C0277558:Familial disease [Disease or Syndrome]
   862 E C0344339:family disease [Finding]
   840   C0030567:Parkinson Disease [Disease or Syndrome]
   840   C1521736:Parkinson's Disease [Functional Concept]
   840   C2681933:PARKINSON DISEASE [Gene or Genome]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   704   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.11: One explanation for the formation of perikaryal and neuritic aggregates of -synuclein, which is a presynaptic protein, is that the mutations disrupt -synuclein transport and lead to its proximal accumulation. 

Phrase: "One explanation for the formation of perikaryal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0681841:Explanation [Intellectual Product]

Phrase: "and"

Phrase: "neuritic aggregates of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "which"

Phrase: "is"

Phrase: "a presynaptic protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "that"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "disrupt -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "lead to its proximal accumulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0205107:Proximal [Spatial Concept]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.12: We found that mutant forms of -synuclein, either associated with Parkinson's disease (A30P or A53T) or mimicking defined serine, but not tyrosine, phosphorylation states exhibit reduced axonal transport following transfection into cultured neurons. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that mutant forms of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "either"

Phrase: "associated with Parkinson's disease"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   833   C0030567:Parkinson Disease [Disease or Syndrome]
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   833   C1521736:Parkinson's Disease [Functional Concept]
   833   C2681933:PARKINSON DISEASE [Gene or Genome]
   819   C0243083:associated disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "(A30P"

Phrase: "or"

Phrase: "A53T"

Phrase: ")"

Phrase: "or"

Phrase: "mimicking defined serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "but"

Phrase: "not tyrosine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phosphorylation states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0004462:Axonal Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   755   C0004461:Axon [Cell Component]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfection into cultured neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.13: Furthermore, transfection of A30P, but not wild-type, -synuclein results in accumulation of the protein proximal to the cell body. 

Phrase: "Furthermore,"

Phrase: "transfection of A30P,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "but"

Phrase: "not wild-type, -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "results in accumulation of the protein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "proximal to the cell body."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205107:Proximal [Spatial Concept]
Processing 00000000.tx.14: We propose that the reduced axonal transport exhibited by the Parkinson's disease-associated -synuclein mutants examined in this study might contribute to perikaryal accumulation of -synuclein and hence Lewy body formation and neuritic abnormalities in diseased brain. 

Phrase: "We"

Phrase: "propose"

Phrase: "that"

Phrase: "the reduced axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0004462:Axonal Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   755   C0004461:Axon [Cell Component]

Phrase: "exhibited by the Parkinson's disease-"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   760   C0012634:Disease [Disease or Syndrome]
   726   C0015272:Exhibit [Intellectual Product]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "associated -"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "synuclein mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "examined in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332128:Examined [Finding]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "might"

Phrase: "contribute to perikaryal accumulation of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "hence Lewy body formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0220781:formation [Biologic Function]
   812   C0439634:formation [Spatial Concept]
   812   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "neuritic abnormalities in diseased brain."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0000768:Abnormalities [Congenital Abnormality]
   760   C0000769:abnormalities [Functional Concept]
   726 E C1704258:Abnormality [Finding]
Processing 00000000.tx.15: Key words: Synuclein, Axonal transport, Lewy body, Parkinson's disease, Aggregation, Neurodegeneration  Introduction Top Summary Introduction Materials and Methods Results Discussion References  -Synuclein is a 14 kDa phosphoprotein of 140 amino acids that was first identified as a presynaptic protein in rat brain (Maroteaux et al., 1988). 

Phrase: "Key words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "Synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Axonal transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "Lewy body,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0085200:Lewy Body [Cell Component]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   777 E C1995017:Bodies [Cell Component]

Phrase: "Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "Aggregation,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332621:Aggregation [Functional Concept]
  1000   C0439168:% aggregation [Quantitative Concept]
   928 E C0205418:Aggregate [Qualitative Concept]

Phrase: "Neurodegeneration  Introduction Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion References  -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a 14 kDa phosphoprotein of 140 amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0031689:Phosphoprotein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "identified as a presynaptic protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205396:Identified [Qualitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "in rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(Maroteaux et al.,"

Phrase: "1988"

Phrase: ")."
Processing 00000000.tx.16: The normal function of -synuclein remains unknown, although it might be involved in synaptic plasticity (George et al., 1995), maintenance of the synaptic vesicle pool (Murphy et al., 2000) and regulation of dopamine biosynthesis (Perez et al., 2002). 

Phrase: "The normal function of -synuclein remains"

Phrase: "unknown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "although"

Phrase: "it"

Phrase: "might"

Phrase: "be"

Phrase: "involved in synaptic plasticity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0678558:Plasticity [Natural Phenomenon or Process]
   770   C1314939:Involved [Functional Concept]

Phrase: "(George et al.,"

Phrase: "1995"

Phrase: ")"

Phrase: ","

Phrase: "maintenance of the synaptic vesicle pool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "(Murphy et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "regulation of dopamine biosynthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   881   C1157723:regulation of biosynthesis [Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "(Perez et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.17: Two pieces of evidence suggest that -synuclein has a causal role in neurodegenerative disease: (1) two rare point mutations in -synuclein (Ala53Thr and Ala30Pro) have been found in a few families with autosomal dominant Parkinson's disease (Polymeropoulos et al., 1997; Kruger et al., 1998); 

Phrase: "Two pieces of evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C2982836:Piece [Quantitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a causal role in neurodegenerative disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "two rare point mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Ala53Thr"

Phrase: "and"

Phrase: "Ala30Pro"

Phrase: ")"

Phrase: "have"

Phrase: "been"

Phrase: "found in a few families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0015576:Families [Family Group]
   760   C0150312:Found [Quantitative Concept]
   760   C1704727:Family [Conceptual Entity]
   726 E C0243095:Find [Finding]

Phrase: "with autosomal dominant Parkinson's disease"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C3489791:Parkinson Disease, Autosomal Dominant [Disease or Syndrome]
   861   C0030567:Parkinson Disease [Disease or Syndrome]
   861   C1521736:Parkinson's Disease [Functional Concept]
   861   C2681933:PARKINSON DISEASE [Gene or Genome]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   712   C1021144:Parkinsonia [Plant]

Phrase: "(Polymeropoulos et al.,"

Phrase: "1997"

Phrase: "; Kruger et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.18: (2) -synuclein accumulates in Lewy bodies and other pathological inclusions in conditions including Parkinson's disease, multiple system atrophy, neurodegeneration with brain iron accumulation and Alzheimer's disease (Masliah et al., 1996; Spillantini et al., 1997; Lippa et al., 1998; Spillantini et al., 1998; Gai et al., 1998; Irizarry et al., 1998; Braak et al., 1999; Iwanaga et al., 1999; Hamilton, 2000), thus highlighting its importance in the pathogenesis of these neurodegenerative disorders. 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ") -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "accumulates in Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "other pathological inclusions in conditions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1512693:Inclusion [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Parkinson's disease,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "multiple system atrophy,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "neurodegeneration with brain iron accumulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(Masliah et al.,"

Phrase: "1996"

Phrase: "; Spillantini et al.,"

Phrase: "1997"

Phrase: "; Lippa et al.,"

Phrase: "1998"

Phrase: "; Spillantini et al.,"

Phrase: "1998"

Phrase: "; Gai et al.,"

Phrase: "1998"

Phrase: "; Irizarry et al.,"

Phrase: "1998"

Phrase: "; Braak et al.,"

Phrase: "1999"

Phrase: "; Iwanaga et al.,"

Phrase: "1999"

Phrase: "; Hamilton,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "thus"

Phrase: "highlighting"

Phrase: "its importance in the pathogenesis of these neurodegenerative disorders."
Processing 00000000.tx.19: Furthermore, overexpression of -synuclein in Drosophila (Feany et al., 2000) and transgenic mice (Masliah et al., 2000; Kahle et al., 2000) results in pathological accumulation of -synuclein and neuronal dysfunction. 

Phrase: "Furthermore,"

Phrase: "overexpression of -synuclein in Drosophila"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Feany et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "(Masliah et al.,"

Phrase: "2000"

Phrase: "; Kahle et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "results in pathological accumulation of -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030664:Pathological [Biomedical Occupation or Discipline]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1274040:Result [Functional Concept]
   753   C1521733:Pathological [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "and"

Phrase: "neuronal dysfunction."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.20: Thus, overexpression of -synuclein within distinct subcellular compartments might lead to the formation of perikaryal Lewy bodies and other pathological accumulations of -synuclein. 

Phrase: "Thus,"

Phrase: "overexpression of -synuclein within distinct subcellular compartments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "lead to the formation of perikaryal Lewy bodies"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   770   C0085200:Lewy Bodies [Cell Component]
   744   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   744   C0220781:formation [Biologic Function]
   744   C0242821:bodies [Human]
   744   C0439634:formation [Spatial Concept]
   744   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   744   C1522492:Formation [Functional Concept]
   744   C1522538:Lead [Functional Concept]
   744   C1995017:Bodies [Cell Component]
   744   C2348269:Lead [Element, Ion, or Isotope]
   744   C3275067:LEAD [Therapeutic or Preventive Procedure]
   711 E C0460148:Body [Anatomical Structure]
   711 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "other pathological accumulations of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.21: -Synuclein is actively transported from its site of synthesis in the cell body along axons to synaptic termini. 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "actively"

Phrase: "transported from its site of synthesis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C2945843:Site of [Qualitative Concept]
   753   C0205145:Site [Spatial Concept]
   753   C0220781:synthesis [Biologic Function]
   753   C1515974:Site [Body Location or Region]
   753   C1883254:Synthesis [Activity]
   753   C2825164:Site [Spatial Concept]
   719   C0005528:Transport, NOS [Cell Function]
   719   C1317949:Transport [Manufactured Object]
   719   C3495449:transport [Medical Device]

Phrase: "in the cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "along axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "to synaptic termini."
Processing 00000000.tx.22: Metabolic labelling of neuronal proteins in the rat optic nerve has shown that most -synuclein (76%) moves in the slow component of axonal transport (Jensen et al., 1998; Jensen et al., 1999). 

Phrase: "Metabolic labelling of neuronal proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "in the rat optic nerve"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C1882801:Rat Optic Nerve [Body Part, Organ, or Organ Component]
   901   C0029130:Optic Nerve [Body Part, Organ, or Organ Component]
   901   C1268985:Optic nerve [Body Part, Organ, or Organ Component]
   827   C0015392:Optic [Body Part, Organ, or Organ Component]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0029144:optic [Occupation or Discipline]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "has"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that most -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(76%"

Phrase: ")"

Phrase: "moves in the slow component of axonal transport"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   793   C0598956:slow axonal transport [Cell Function]
   770   C0004462:Axonal Transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0439834:Slow [Qualitative Concept]
   744   C0449432:Component [Manufactured Object]
   744   C0560560:move [Organism Function]
   744   C0578671:Moves [Finding]
   744   C1269909:move [Functional Concept]
   744   C1299988:move [Functional Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
   744   C2699029:Move [Activity]
   744   C3495449:transport [Medical Device]

Phrase: "(Jensen et al.,"

Phrase: "1998"

Phrase: "; Jensen et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.23: A proportion of -synuclein also binds to vesicles and is moved in the fast component of axonal transport. 

Phrase: "A proportion of -synuclein also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "binds to vesicles"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0333262:VESICLES [Acquired Abnormality]
   790   C1145667:Bind [Activity]
   790   C1167622:bind [Molecular Function]
   756 E C1622418:vesicle [Cell Component]
   706 E C0205378:Vesicular [Qualitative Concept]

Phrase: "and"

Phrase: "is"

Phrase: "moved in the fast component of axonal transport."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   793   C0598954:fast axonal transport [Cell Function]
   770   C0004462:Axonal Transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0015663:Fast [Finding]
   744   C0449432:Component [Manufactured Object]
   744   C0456962:Fast [Qualitative Concept]
   744   C1269909:moved [Functional Concept]
   744   C1299988:moved [Functional Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
   744   C2699029:Moved [Activity]
   744   C3495449:transport [Medical Device]
   711 E C0560560:move [Organism Function]
   711 E C0578671:move [Finding]
Processing 00000000.tx.24: Binding of -synuclein to vesicles is reduced in A30P -synuclein, suggesting that this mutation might compromise the fast axonal transport of -synuclein, although the direct effects of -synuclein mutations on its transport have not yet been examined (Jensen et al., 1998; Jo et al., 2002). 

Phrase: "Binding of -synuclein to vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "reduced in A30P -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "might"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "the fast axonal transport of -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   717   C0598954:fast axonal transport [Cell Function]

Phrase: "although"

Phrase: "the direct effects of -synuclein mutations on its transport"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "(Jensen et al.,"

Phrase: "1998"

Phrase: "; Jo et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.25: It is conceivable that defective -synuclein transport could lead to less -synuclein exiting from the cell body along the axon and effectively cause local overexpression of -synuclein in the perikaryon. 

Phrase: "It"

Phrase: "is"

Phrase: "conceivable"

Phrase: "that defective -synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]

Phrase: "could"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to less -synuclein exiting from the cell body"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0337094:exiting [Spatial Concept]
   711 E C1550550:exit [Temporal Concept]

Phrase: "along the axon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]

Phrase: "and"

Phrase: "effectively"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "local overexpression of -synuclein in the perikaryon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.26: Such overexpression might alter the normal cellular localization of -synuclein and affect its folding and/or association with other proteins, leading to its accumulation as Lewy bodies. 

Phrase: "Such overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "might"

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "the normal cellular localization of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "its folding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185026:Folding [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "association with other proteins,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "leading to its accumulation"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "as Lewy bodies."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]
Processing 00000000.tx.27: Phosphorylation of -synuclein on serine residues diminishes its affinity for vesicles (Okochi et al., 2000; Pronin et al., 2000), suggesting that, as is likely to be the case for neurofilaments and microtubule-associated protein 1B, the phosphorylation state of -synuclein might regulate its axonal transport (Jung et al., 2000). 

Phrase: "Phosphorylation of -synuclein on serine residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "diminishes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205216:diminish [Quantitative Concept]

Phrase: "its affinity for vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "(Okochi et al.,"

Phrase: "2000"

Phrase: "; Pronin et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that,"

Phrase: "as is likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332148:Likely [Qualitative Concept]
   812   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "the case for neurofilaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "microtubule-associated protein 1B,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0250759:microtubule-associated protein 1B [Amino Acid, Peptide, or Protein]
  1000   C1417004:MICROTUBULE-ASSOCIATED PROTEIN 1B [Gene or Genome]
   923   C0026045:Microtubule-associated protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0026046:Micro-tubule [Cell Component]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0332281:Associated [Qualitative Concept]
   812   C0450345:1B [Intellectual Product]
   779 E C0750490:Associate [Idea or Concept]
   779 E C1706221:Associate [Professional or Occupational Group]

Phrase: "the phosphorylation state of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "regulate"

Phrase: "its axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "(Jung et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.28: In addition to phosphorylation of -synuclein on serine residues, tyrosine phosphorylation of -synuclein has also been reported, both in vitro and in cells (Nakamura et al., 2001; Ellis et al., 2001; Negro et al., 2002; Nakamura et al., 2002). 

Phrase: "In addition to phosphorylation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "on serine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "tyrosine phosphorylation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: ","

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1515981:And [Idea or Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "(Nakamura et al.,"

Phrase: "2001"

Phrase: "; Ellis et al.,"

Phrase: "2001"

Phrase: "; Negro et al.,"

Phrase: "2002"

Phrase: "; Nakamura et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.29: However, any effects of tyrosine or serine phosphorylation of -synuclein on its axonal transport have not been determined and this is one of the purposes of this study. 

Phrase: "However,"

Phrase: "any effects of tyrosine"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "or"

Phrase: "serine phosphorylation of -synuclein on its axonal transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: "and"

Phrase: "this"

Phrase: "is"

Phrase: "one of the purposes of this study."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]
Processing 00000000.tx.30: We have investigated the effects of the Parkinson's disease-associated A30P and A53T mutations in -synuclein on its axonal transport in cultured rat brain cortical neurons. 

Phrase: "We"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the effects of the Parkinson's disease-associated A30P"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A53T mutations in -synuclein on its axonal transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in cultured rat brain cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.31: We have also examined the transport of -synuclein mutants that mimic serine or tyrosine phosphorylation at three defined sites to determine whether these phosphorylation states have a role in the regulation of -synuclein transport in neurons.  

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the transport of -synuclein mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "mimic"

Phrase: "serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "or"

Phrase: "tyrosine phosphorylation at three defined sites to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C1519727:Tyrosine Phosphorylation Site [Amino Acid Sequence]
   778   C1519726:Tyrosine Phosphorylation [Molecular Function]
   757   C1519063:Phosphorylation Site [Amino Acid Sequence]
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "determine"

Phrase: "whether"

Phrase: "these phosphorylation states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "have"

Phrase: "a role in the regulation of -synuclein transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.32: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion References  Expression constructs and site-directed mutagenesis of -synuclein Human -synuclein cDNA (gift from M. Goedert, Cambridge) was cloned into the EcoRV and HindIII sites of pcDNA 3.1() (Invitrogen) or pEGFP-C (BD Biosciences). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Expression constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "site-directed mutagenesis of -synuclein Human -synuclein cDNA (gift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   720   C0423899:Gifted [Finding]

Phrase: "from M. Goedert,"

Phrase: "Cambridge"

Phrase: ")"

Phrase: "was"

Phrase: "cloned into the EcoRV"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0009013:cloned [Cell]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "HindIII sites of pcDNA 3.1"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C2945843:Site of [Qualitative Concept]
   753   C0205145:Sites [Spatial Concept]
   719 E C1515974:Site [Body Location or Region]
   719 E C2825164:Site [Spatial Concept]

Phrase: "("

Phrase: ")"

Phrase: "(Invitrogen"

Phrase: ")"

Phrase: "or"

Phrase: "pEGFP-C (BD Biosciences"

Phrase: ")."
Processing 00000000.tx.33: Site-directed mutagenesis of wild-type -synuclein in pcDNA 3.1() was performed to generate mutant constructs using the polymerase chain reaction (Hemsley et al., 1989). 

Phrase: "Site-directed mutagenesis of wild-type -synuclein"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   774   C2945843:Site of [Qualitative Concept]
   748   C0079866:Mutagenesis [Molecular Function]
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]
   748   C3146302:Mutagenesis [Laboratory Procedure]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "in pcDNA 3.1"

Phrase: "("

Phrase: ")"

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "mutant constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polymerase chain reaction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "(Hemsley et al.,"

Phrase: "1989"

Phrase: ")."
Processing 00000000.tx.34: The mutagenic oligonucleotides used were: A30P, 5'-CAGAAGCGCCTGGAAAGA-3' A53T, 5'-CATGGTGTCACAACAGTG-3' S87D, 5'-TGGAGGGCGCCGGGGACATTGCA-3' S87A, 5'-TGGAGGGCGCCGGGGCCATTGCA-3' S129D, 5'-AACTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCATCAGGCATTTCA-3' S129A, 5'-AACTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCAGCAGGCATTTCA-3' Y125D, 5'-CTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGGTACCCTTCCTCAGAAGGCATTTCATCAGCCTCATTG-3' Y125F, 5'-CTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCAGAAGGCATTTCGAAAGCCTCATTG-3'. 

Phrase: "The mutagenic oligonucleotides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0028953:Oligonucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: ":"

Phrase: "A30P,"

Phrase: "5'-CAGAAGCGCCTGGAAAGA-3' A53T,"

Phrase: "5'-CATGGTGTCACAACAGTG-3' S87D,"

Phrase: "5'-TGGAGGGCGCCGGGGACATTGCA-3' S87A,"

Phrase: "5'-TGGAGGGCGCCGGGGCCATTGCA-3' S129D,"

Phrase: "5'-AACTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCATCAGGCATTTCA-3' S129A,"

Phrase: "5'-AACTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCAGCAGGCATTTCA-3' Y125D,"

Phrase: "5'-CTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGGTACCCTTCCTCAGAAGGCATTTCATCAGCCTCATTG-3' Y125F,"

Phrase: "5'-CTTAAGCTTTTAGGCTTCAGGTTCGTAGTCTTGATACCCTTCCTCAGAAGGCATTTCGAAAGCCTCATTG-3'."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.35: All mutations were confirmed by DNA sequencing (Oswel Research Products). 

Phrase: "All mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "confirmed by DNA sequencing"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0162326:DNA sequencing [Nucleotide Sequence]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C0917792:DNA Sequencing [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Oswel Research Products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.36: A plasmid expressing the targeting sequence from subunit VIII of cytochrome c oxidase tagged with the fluorescent protein pDsRed2-C was used to label mitochondria (BD Biosciences). 

Phrase: "A plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the targeting sequence from subunit VIII of cytochrome c oxidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "tagged with the fluorescent protein pDsRed2-C"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   774   C0033621:Protein C [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   774   C1168438:Protein C [Laboratory Procedure]
   774   C1418943:PROTEIN C [Gene or Genome]
   774   C3540567:Protein C [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1818826:protein tag [Molecular Function]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   748   C1708632:Tagged [Qualitative Concept]
   714 E C0037293:Tag [Neoplastic Process]
   714 E C0181496:Tag [Manufactured Object]
   714 E C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "used to label mitochondria"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0026237:Mitochondria [Cell Component]
   770   C0181496:Label [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2827499:Label [Governmental or Regulatory Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(BD Biosciences"

Phrase: ")."
Processing 00000000.tx.37: Transfection and treatment of rat cortical neuronal cultures Cortical neuronal cultures 5 days in vitro (DIV) were prepared from embryonic day 18 rats as previously described (Davis et al., 1995). 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "treatment of rat cortical neuronal cultures Cortical neuronal cultures 5 days in vitro (DIV)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   735   C0039798:treatment [Functional Concept]
   735   C0087111:Treatment [Therapeutic or Preventive Procedure]
   735   C1522326:Treatment [Functional Concept]
   735   C1533734:Treatment [Therapeutic or Preventive Procedure]
   735   C1705169:Treatment [Conceptual Entity]
   735   C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "prepared from embryonic day 18 rats"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0013935:Embryonic [Embryonic Structure]
   753   C0034693:rats [Mammal]
   753   C0034721:Rats [Mammal]
   753   C0332173:/day [Temporal Concept]
   753   C0439228:day [Temporal Concept]
   753   C0439505:/day [Temporal Concept]
   719   C1521827:Prepare [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Davis et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.38: Cells were transfected with plasmids containing human wild-type or mutant -synuclein using calcium phosphate (Xia et al., 1996), followed by 5% (v/v) glycerol, 2% (v/v) dimethyl sulfoxide (Ackerley et al., 2000) for 2 minutes (glycerol shock). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "calcium phosphate"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
  1000   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
  1000   C1161320:calcium phosphate [Pharmacologic Substance]
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   861   C0031701:phosphate [Organophosphorus Compound]
   861   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(Xia et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "followed by 5%"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "(v/v) glycerol,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   734   C0560268:%V/V [Quantitative Concept]
   734   C2349105:V(V) [Element, Ion, or Isotope]

Phrase: "2%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "(v/v) dimethyl sulfoxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   812   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0038771:sulfoxide [Organic Chemical]
   812   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "for 2 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0439232:minute [Temporal Concept]
   861   C0700321:minute [Quantitative Concept]
   861   C0702093:/minute [Temporal Concept]
   861   C1282918:Minute [Quantitative Concept]
   861   C2347166:Minute [Quantitative Concept]

Phrase: "(glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: ")."
Processing 00000000.tx.39: In some experiments, 3.5 hours after the glycerol shock, cells were exposed to either 0.05% (w/v) sodium azide and 50 mM 2-deoxy-D-glucose for 30 minutes or 2 g ml1 cycloheximide for the duration of the experiment (Furukawa et al., 1997). 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "3.5 hours after the glycerol shock,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   774   C1442460:3 Hours [Temporal Concept]
   748   C0439227:hours [Temporal Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "exposed to either 0.05%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "sodium azide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   861   C0004492:azide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "50 mM 2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose for 30 minutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "2 g ml1 cycloheximide for the duration of the experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0010572:Cycloheximide [Antibiotic,Organic Chemical]

Phrase: "(Furukawa et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.40: Measurement of -synuclein axonal transport To determine overall rates of axonal transport, we measured the distances travelled by exogenous -synuclein along axons following transfection into rat cortical neurons. 

Phrase: "Measurement of -synuclein axonal transport To"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0004462:Axonal Transport [Cell Function]
   827   C1550030:Transport To [Idea or Concept]
   799   C0005528:Transport, NOS [Cell Function]
   799   C1317949:Transport [Manufactured Object]
   799   C3495449:transport [Medical Device]
   727   C0004461:Axon [Cell Component]

Phrase: "determine"

Phrase: "overall rates of axonal transport,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:distances [Quantitative Concept]
   916 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by exogenous -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0205101:Exogenous [Spatial Concept]
   770   C0205228:Exogenous [Functional Concept]
   737   C0040802:travel [Daily or Recreational Activity]
   737   C1555670:travel [Idea or Concept]

Phrase: "along axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfection into rat cortical neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.41: Cultures were fixed in 4% (w/v) paraformaldehyde and permeabilized for 2 minutes in 0.1% (w/v) Triton X-100 at 30 minute intervals from 2.5-6 hours after glycerol shock, some cultures were also fixed 24 hours after transfection. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "fixed in 4%"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C2827483:Fixed [Body Substance]

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "permeabilized for 2 minutes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0439232:minute [Temporal Concept]
   770   C0700321:minute [Quantitative Concept]
   770   C0702093:/minute [Temporal Concept]
   770   C1282918:Minute [Quantitative Concept]
   770   C2347166:Minute [Quantitative Concept]

Phrase: "in 0.1%"

Phrase: "(w/v"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0560267:%W/V [Quantitative Concept]

Phrase: ")"

Phrase: "Triton X-100 at 30 minute intervals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   778   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   748   C0242759:Triton [Geographic Area]

Phrase: "from 2.5-6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C1292425:2 Hours [Temporal Concept]
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "after glycerol shock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "some cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "also"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "24 hours after transfection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0439584:24 hours [Temporal Concept]
   833   C0456696:/24 hours [Temporal Concept]
   833   C1442770:24 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.42: Neurons transfected with untagged -synuclein were labelled with the rabbit polyclonal antibody to -synuclein, 90. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "transfected with untagged -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "labelled with the rabbit polyclonal antibody to -synuclein,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0034493:Rabbit [Mammal]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   711   C0181496:Label [Manufactured Object]
   711   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "90."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]
Processing 00000000.tx.43: Expression of enhanced green fluorescent protein (EGFP)- and DsRed2-tagged constructs was detected by direct fluorescence. 

Phrase: "Expression of enhanced green fluorescent protein (EGFP)-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   716   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "DsRed2-tagged constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "detected by direct fluorescence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0016315:Fluorescence [Natural Phenomenon or Process]
   770   C0439851:Direct [Qualitative Concept]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.44: Axonal distribution of -synuclein was demonstrated by double staining with a rabbit polyclonal antibody to tau, TP70 (Brion et al., 1993). 

Phrase: "Axonal distribution of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "demonstrated by double staining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0205173:Double [Functional Concept]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   770   C1705764:Double [Activity]
   770   C1705765:Double [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "with a rabbit polyclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "TP70"

Phrase: "(Brion et al.,"

Phrase: "1993"

Phrase: ")."
Processing 00000000.tx.45: Images of transfected neurons were captured digitally and axonal transport was measured using Metamorph software (Universal Imaging) as the distance travelled by the fluorescent front from the point where the axon exits the cell body to the most distal point at which fluorescence was detectable above background in the longest, most brightly stained, neurite of transfected neurons. 

Phrase: "Images of transfected neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1704254:Image [Intellectual Product]
   737   C1704922:Image [Entity]
   737   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "digitally"

Phrase: "and"

Phrase: "axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Metamorph software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Universal Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0011923:Imaging [Diagnostic Procedure]
   861   C0079595:Imaging [Diagnostic Procedure]
   827 E C1704254:Image [Intellectual Product]
   827 E C1704922:Image [Entity]
   827 E C3542466:Image [Intellectual Product]

Phrase: ")"

Phrase: "as the distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:Distance [Quantitative Concept]
   928 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by the fluorescent front"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205094:front [Spatial Concept]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726   C0040802:travel [Daily or Recreational Activity]
   726   C1555670:travel [Idea or Concept]

Phrase: "from the point where"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1552961:Point [Quantitative Concept]
   861   C2347617:point [Quantitative Concept]

Phrase: "the axon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axon [Cell Component]

Phrase: "exits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337094:Exit [Spatial Concept]
  1000   C1550550:exit [Temporal Concept]

Phrase: "the cell body to the most distal point"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0007634:THE CELL [Cell]
           Cell
   770   C0599444:Cell body [Cell Component]
   770   C2752549:cell body [Cell Component]
   744   C0242821:body [Human]
   744   C0460148:Body [Anatomical Structure]
   744   C1268086:Body [Anatomical Structure]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "at which fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016315:Fluorescence [Natural Phenomenon or Process]
   928 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "detectable above background in the longest, most brightly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1706907:Background [Conceptual Entity]

Phrase: "stained"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2986582:Stained [Qualitative Concept]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: ","

Phrase: "neurite of transfected neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085103:Neurite [Cell Component]
Processing 00000000.tx.46: A single measurement was obtained for each transfected neuron and this value corresponded to the furthest detectable distance travelled by -synuclein. 

Phrase: "A single measurement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:Measurement [Functional Concept]

Phrase: "was"

Phrase: "obtained for each transfected neuron"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0027882:Neuron [Cell]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "this value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "corresponded to the furthest detectable distance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0456966:Far distance [Finding]
   753   C0012751:Distance [Quantitative Concept]
   719   C0205108:far [Spatial Concept]

Phrase: "travelled by -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0040802:travel [Daily or Recreational Activity]
   756   C1555670:travel [Idea or Concept]
Processing 00000000.tx.47: To eliminate potential subjectivity, transport measurements were determined by observers blinded to the experimental conditions in each case. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "potential subjectivity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C0439655:Subjective [Qualitative Concept]
   789   C2979880:Subjective [Intellectual Product]

Phrase: "transport measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "determined by observers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0870992:observers [Professional or Occupational Group]

Phrase: "blinded to the experimental conditions"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   760   C0150108:Blinded [Research Activity]
   760   C1517586:Experimental [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726 E C0456909:Blind [Disease or Syndrome]
   726 E C0525065:blind [Patient or Disabled Group]
   726   C1705253:Condition [Conceptual Entity]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "in each case."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.48: Results are expressed as means.e.m. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as means.e.m."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1704970:Means [Conceptual Entity]
   726 E C0444504:Mean [Quantitative Concept]
   726 E C2347634:Mean [Quantitative Concept]
   726 E C2348143:Mean [Quantitative Concept]
Processing 00000000.tx.49: (n), where n is the number of neurons measured under each experimental condition, and Student's t test was used for statistical analysis. 

Phrase: "(n), where n"

Phrase: "is"

Phrase: "the number of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "measured under each experimental condition,"
Meta Candidates (Total=13; Excluded=7; Pruned=0; Remaining=6)
   760   C0012634:condition [Disease or Syndrome]
   760   C0348080:Condition [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C1517586:Experimental [Qualitative Concept]
   760   C1705253:Condition [Conceptual Entity]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   704 E C0040607:Training [Educational Activity]
   704 E C0220931:Training [Educational Activity]
   704 E C0336809:Train [Manufactured Object]
   704 E C1552514:Train [Manufactured Object]
   704 E C2673163:training [Qualitative Concept]

Phrase: "and"

Phrase: "Student's t test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "was"

Phrase: "used for statistical analysis."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0871424:statistical analysis [Research Activity]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0038215:Statistical [Occupation or Discipline]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.50: Because the neurons were transfected at 5 DIV, a time at which the neurons extend long axonal processes whose average length exceeds 700 m (Ackerley et al., 2000), the distance travelled from the cell body by the exogenous -synuclein in these cultures reflects -synuclein transport rather than neurite growth rate. 

Phrase: "Because"

Phrase: "the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "transfected at 5 DIV,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "a time at which"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "long axonal processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "whose average length"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C1444754:Length [Quantitative Concept]
   861   C1510992:Average [Quantitative Concept]
   861   C1706316:LENGTH [Research Activity]
   861   C2825518:AVERAGE [Quantitative Concept]
   789 E C0205166:Long [Qualitative Concept]
   789 E C1522425:Longest [Qualitative Concept]
   789 E C1706317:Long [Qualitative Concept]

Phrase: "exceeds"

Phrase: "700"

Phrase: "m ("

Phrase: "Ackerley et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "the distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:Distance [Quantitative Concept]
   928 E C0443203:Distant [Spatial Concept]

Phrase: "travelled from the cell body"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0599444:Cell body [Cell Component]
   806   C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0040802:travel [Daily or Recreational Activity]
   726   C1555670:travel [Idea or Concept]

Phrase: "by the exogenous -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in these cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "reflects -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "rather than"

Phrase: "neurite growth rate."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0449249:Growth rate [Temporal Concept]
   901   C1753129:neurite growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2911660:Growth [Activity]
Processing 00000000.tx.51: We have shown previously that this long neurite has axonal properties (tau positive, MAP2 negative) and that the shorter neurites surrounding the cell body are dendritic (tau negative, MAP2 positive) (Utton et al., 2002). 

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "previously"

Phrase: "that"

Phrase: "this long neurite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurite [Cell Component]

Phrase: "has"

Phrase: "axonal properties"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0871161:properties [Qualitative Concept]
   861   C1292721:properties [Functional Concept]
   827 E C1882134:Property [Conceptual Entity]
   827 E C2347695:Property [Entity]

Phrase: "(tau positive,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "MAP2 negative"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "that"

Phrase: "the shorter neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurites [Cell Component]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "are"

Phrase: "dendritic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011305:Dendritic [Cell Component]
  1000   C0439640:Dendritic [Qualitative Concept]

Phrase: "(tau negative,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205160:Negative [Qualitative Concept]
   861   C1513916:Negative [Finding]
   861   C2825415:Negative [Conceptual Entity]
   861   C2825491:Negative [Qualitative Concept]

Phrase: "MAP2 positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: ")"

Phrase: "(Utton et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.52: Measurements of axonal transport were made only in neuronal cultures in which the transfection efficiency exceeded 1%. 

Phrase: "Measurements of axonal transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "only in neuronal cultures"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0010453:Cultures [Idea or Concept]
   770   C0205171:Only [Quantitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1720467:Only [Intellectual Product]
   737 E C0220814:culture [Functional Concept]
   737 E C0430400:Culture [Laboratory Procedure]
   737 E C2242979:Culture [Laboratory Procedure]

Phrase: "in which"

Phrase: "the transfection efficiency"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013682:Efficiency [Quantitative Concept]
   861   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   789 E C0442799:Efficient [Qualitative Concept]

Phrase: "exceeded"

Phrase: "1%."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.53: The time of glycerol shock was taken as the zero time in all experiments from which measurements were obtained (Ackerley et al., 2000). 

Phrase: "The time of glycerol shock"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "was"

Phrase: "taken as the zero time"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0919414:Zero [Quantitative Concept]
   760   C1883727:Taken [Conceptual Entity]
   760   C3541383:Time [Temporal Concept]
   726 E C1515187:Take [Health Care Activity]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "in all experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "from which measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.54: Typically, 20-30 morphologically normal, transfected neurons were measured on each coverslip and each experiment was repeated a minimum of three times. 

Phrase: "Typically,"

Phrase: "20-30 morphologically normal, transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0027882:Neurons [Cell]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "measured on each coverslip"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "and"

Phrase: "each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "a minimum of three times."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1524031:Minimum [Qualitative Concept]
   760   C1552614:minimum [Idea or Concept]
   760   C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.55: To estimate the relative amounts of -synuclein protein expression by wild-type and mutant -synuclein plasmids, neurons were labelled with 90 at 4 hours after transfection and the average immunofluorescence intensity of each neuronal cell body was measured using a Zeiss Axioscope (Carl Zeiss) and Metamorph software for image capture. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "estimate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimate [Quantitative Concept]

Phrase: "the relative amounts of -synuclein protein expression by wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1171362:protein expression [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "mutant -synuclein plasmids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "labelled with 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   756   C0181496:Label [Manufactured Object]
   756   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at 4 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292426:4 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "the average immunofluorescence intensity of each neuronal cell body"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Zeiss Axioscope"

Phrase: "(Carl Zeiss"

Phrase: ")"

Phrase: "and"

Phrase: "Metamorph software for image capture."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.56: The background intensity of an area equivalent to each cell body was subtracted from the total immunofluorescence in a minimum of 80 neurons transfected with plasmids expressing wild-type or mutant -synuclein and the net immunofluorescence values were compared using Student's t test. 

Phrase: "The background intensity of an area equivalent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0522510:Intensity [Qualitative Concept]

Phrase: "to each cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "subtracted from the total immunofluorescence"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0016318:Immunofluorescence [Laboratory Procedure]
   760   C0079603:Immunofluorescence [Laboratory Procedure]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   726   C1719767:Subtract [Intellectual Product]
   726   C2348589:Subtract [Phenomenon or Process]
   704 E C0282648:Direct immunofluorescence [Laboratory Procedure]

Phrase: "in a minimum"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1524031:Minimum [Qualitative Concept]
  1000   C1552614:minimum [Idea or Concept]
  1000   C2826545:MINIMUM [Quantitative Concept]
   928 E C0547040:Minimal [Qualitative Concept]
   928 E C2945599:Minimal [Qualitative Concept]

Phrase: "of 80 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "the net immunofluorescence values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0042295:Values [Qualitative Concept]
   793 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "compared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Student's t test."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]
Processing 00000000.tx.57: Cell death was assessed by bis-benzimide (Sigma-Aldrich) staining of nuclei and by determining the proportion of cells exhibiting nuclear condensation, fragmentation or retraction of neuronal processes. 

Phrase: "Cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "assessed by bis-benzimide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0556985:BIS [Temporal Concept]
   770   C1516048:Assessed [Activity]
   770   C2247301:BIS [Molecular Function]
   770   C3540495:BIS [Intellectual Product]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: "staining of nuclei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0487602:Staining [Laboratory Procedure]
   790   C1704680:Staining [Finding]

Phrase: "and by determining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "the proportion of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709707:Proportion [Quantitative Concept]

Phrase: "exhibiting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:exhibiting [Intellectual Product]

Phrase: "nuclear condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332472:Fragmentation [Anatomical Abnormality]
  1000   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "or"

Phrase: "retraction of neuronal processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332523:Retraction [Finding]
   770   C2825977:Retraction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.58: Cells expressing exogenous -synuclein were excluded from analysis if any of these morphological signs of decreased neuronal viability were observed. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "exogenous -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "excluded from analysis"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]
   790   C1554077:Excluded [Idea or Concept]
   790   C2828389:Excluded [Activity]
   756 E C0332196:Exclude [Functional Concept]

Phrase: "if"

Phrase: "any of these morphological signs of decreased neuronal viability"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   742   C0205216:Decreased [Quantitative Concept]
   742   C0220912:signs [Functional Concept]
   742   C0220913:signs [Manufactured Object]
   742   C0311392:SIGNS [Finding]
   742   C0392756:Decreased [Qualitative Concept]
   742   C0442797:decreased [Qualitative Concept]
   742   C0443348:viability [Qualitative Concept]
   742   C0521390:Neuronal [Immunologic Factor]
   742   C0543482:morphological [Spatial Concept]
   742   C1552551:Any [Qualitative Concept]
   742   C3272371:ANY [Intellectual Product]
   708 E C0547047:Decrease [Quantitative Concept]
   708 E C1547188:Sign [Idea or Concept]

Phrase: "were"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.59: For estimations of protein expression and cell death, 20-50 transfected neurons were analysed on each coverslip and at least three coverslips were counted in each experiment.  

Phrase: "For estimations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0680844:estimations [Mental Process]
   966 E C0681916:Estimation [Quantitative Concept]
   966 E C0750572:Estimation [Quantitative Concept]

Phrase: "of protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "cell death,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "20-50 transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "analysed on each coverslip"

Phrase: "and at least three coverslips"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205449:Three [Quantitative Concept]
   760   C1515981:And [Idea or Concept]

Phrase: "were"

Phrase: "counted in each experiment."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   737   C0750480:Count [Activity]
   737   C1705566:Count [Quantitative Concept]
Processing 00000000.tx.60: Results Top Summary Introduction Materials and Methods Results Discussion References  Transfected wild-type -synuclein is transported along axons in rat cortical neurons The -synuclein antibody used in this study (90), labels both rodent and human -synuclein but, under the experimental conditions described here, rat primary cortical neurons at 5 DIV express very low levels of endogenous rat -synuclein, so we detected only exogenously expressed -synuclein in the transfected neurons. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Transfected wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "transported along axons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0004462:Axonal Transport [Cell Function]
   790   C0004461:Axons [Cell Component]
   756   C0005528:Transport, NOS [Cell Function]
   756   C1317949:Transport [Manufactured Object]
   756   C3495449:transport [Medical Device]

Phrase: "in rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "The -synuclein antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "labels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0181496:labels [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "both rodent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035804:Rodent [Mammal]

Phrase: "and"

Phrase: "human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: ","

Phrase: "under the experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   861   C1517586:Experimental [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here,"

Phrase: "rat primary cortical neurons at 5 DIV"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0205225:Primary [Qualitative Concept]
   742   C0439631:Primary [Therapeutic or Preventive Procedure]

Phrase: "express"

Phrase: "very low levels of endogenous rat -synuclein,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "so"

Phrase: "we"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "only exogenously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205171:Only [Quantitative Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "expressed -"

Phrase: "synuclein in the transfected neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.61: Expression of transfected wild-type human -synuclein in rat primary cortical neurons was first apparent in a few neuronal cell bodies and extended a short distance into the neurites at 2.5 hours after glycerol shock (Fig. 1A). 

Phrase: "Expression of transfected wild-type human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat primary cortical neurons"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   812   C0001613:Cortical [Body Part, Organ, or Organ Component]
   812   C0007776:Cortical [Body Part, Organ, or Organ Component]
   812   C0022655:Cortical [Body Part, Organ, or Organ Component]
   812   C0027882:Neurons [Cell]
   812   C0205225:Primary [Qualitative Concept]
   812   C0439631:Primary [Therapeutic or Preventive Procedure]
   756 E C0234875:bark [Organism Attribute]
   756 E C2700441:Bark [Plant]
   729 E C0205704:Cascara [Organic Chemical,Pharmacologic Substance]
   729 E C0521390:Neuronal [Immunologic Factor]
   729 E C3486388:Cascara [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "first apparent in a few neuronal cell bodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0750489:apparent [Idea or Concept]

Phrase: "and"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "a short distance into the neurites at 2.5 hours"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0012751:Distance [Quantitative Concept]
   739   C1282927:short [Qualitative Concept]
   739   C1806781:Short [Quantitative Concept]
   739   C2350002:Short [Quantitative Concept]

Phrase: "after glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.62: However, by 3.5 hours after transfection, we observed -synuclein immunoreactivity at the extremities of some individual neurites, at long distances from the cell body, indicating that these accumulations represent -synuclein that had already reached the terminals and could have done so in this time if they had travelled at a rate equivalent to that of organelles moving in the fast component of axonal transport (data not shown). 

Phrase: "However,"

Phrase: "by 3.5 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442460:3 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "we"

Phrase: "observed -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "synuclein immunoreactivity at the extremities of some individual neurites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0597879:immunoreactivity [Molecular Function]

Phrase: "at long distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0012751:distances [Quantitative Concept]
   777 E C0443203:Distant [Spatial Concept]

Phrase: "from the cell body,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "indicating"

Phrase: "that"

Phrase: "these accumulations"

Phrase: "represent -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "had"

Phrase: "already"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "the terminals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205088:Terminal [Temporal Concept]
   966   C1705314:Terminal [Manufactured Object]
   966   C1705315:Terminal [Spatial Concept]

Phrase: "and"

Phrase: "could"

Phrase: "have"

Phrase: "done"

Phrase: "so in this time"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0037640:SO [Geographic Area]
   770   C0040223:Time [Temporal Concept]
   770   C3541383:Time [Temporal Concept]
   715 E C0442043:Temporal [Spatial Concept]
   715 E C2362314:Temporal [Temporal Concept]

Phrase: "if"

Phrase: "they"

Phrase: "had"

Phrase: "travelled at a rate equivalent"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205163:Equivalent [Qualitative Concept]
   760   C0439185:equivalent [Quantitative Concept]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726   C0040802:travel [Daily or Recreational Activity]
   726   C1555670:travel [Idea or Concept]

Phrase: "to that"

Phrase: "of organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "moving in the fast component of axonal transport"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   793   C0598954:fast axonal transport [Cell Function]
   770   C0004462:Axonal Transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0015663:Fast [Finding]
   744   C0449432:Component [Manufactured Object]
   744   C0456962:Fast [Qualitative Concept]
   744   C0560560:Moving [Organism Function]
   744   C1317949:Transport [Manufactured Object]
   744   C1705248:Component [Conceptual Entity]
   744   C3495449:transport [Medical Device]
   711 E C0578671:move [Finding]
   711 E C1269909:move [Functional Concept]
   711 E C1299988:move [Functional Concept]
   711 E C2699029:Move [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.63: However, this distally located -synuclein represented only a minor proportion of the total exogenous -synuclein expressed in the cortical neurons and so this was not included in measurements of bulk -synuclein transport. 

Phrase: "However,"

Phrase: "this distally"

Phrase: "located -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a minor proportion of the total exogenous -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709707:Proportion [Quantitative Concept]

Phrase: "expressed in the cortical neurons"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "this"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "included in measurements of bulk -synuclein transport."
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   748   C0005528:Transport, NOS [Cell Function]
   748   C0012173:Bulk [Food]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0242485:measurements [Functional Concept]
   748   C0332257:included [Functional Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C1337615:Bulk [Biomedical or Dental Material]
   748   C3495449:transport [Medical Device]
   748   C3538986:INCLUDED [Gene or Genome]
   714 E C1552866:include [Idea or Concept]
   714 E C2700399:Include [Activity]
Processing 00000000.tx.64: By 6 hours after transfection, -synuclein was present in neuronal cell bodies and also extended along the neurites (Fig. 1A); 

Phrase: "By 6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection, -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "present in neuronal cell bodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "also"

Phrase: "extended along the neurites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0085103:Neurites [Cell Component]
   770   C0231448:Extended [Functional Concept]
   770   C0231449:Extended [Spatial Concept]
   770   C0439792:extended [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.65: by 24 hours, -synuclein was detected along the length of the longest neurite in transfected cells (Fig. 1A). 

Phrase: "by 24 hours, -"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected along the length of the longest neurite"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0085103:Neurite [Cell Component]
   744   C0442726:Detected [Finding]
   744   C1444754:Length [Quantitative Concept]
   744   C1511790:Detected [Therapeutic or Preventive Procedure]
   744   C1706316:LENGTH [Research Activity]

Phrase: "in transfected cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.66: The paucity of expression of endogenous -synuclein in cortical neurons at 5 DIV is illustrated by the absence of 90 labelling of untransfected neurons. 

Phrase: "The paucity of expression of endogenous -synuclein"

Phrase: "in cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "at 5 DIV"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1442466:5 Days [Temporal Concept]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: "is"

Phrase: "illustrated by the absence of 90 labelling of untransfected neurons."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0027882:Neurons [Cell]
   739   C0332197:absence [Quantitative Concept]
   739   C0439083:>90 [Quantitative Concept]
   739   C0439087:<90 [Quantitative Concept]
   739   C1167624:Labeling [Mental Process]
   739   C1689985:Absence [Anatomical Abnormality]
   739   C1947902:Labeling [Manufactured Object]
   739   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.67: Discrete particles of -synuclein were observed in approximately 25% of neurites of transfected neurons at 6 hours after transfection and the frequency of these particles gradually increased until almost all transfected neurons exhibited particulate -synuclein along the length of the longest neurite at 48 hours after transfection. 

Phrase: "Discrete particles of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "observed in approximately 25% of neurites of transfected neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0027882:Neurons [Cell]
   742   C0085103:Neurites [Cell Component]
   742   C0332232:Approximately [Qualitative Concept]
   742   C1441672:Observed [Functional Concept]

Phrase: "at 6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "the frequency of these particles gradually"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "until"

Phrase: "almost"

Phrase: "all transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "particulate -synuclein along the length of the longest neurite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "at 48 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0439586:48 hours [Temporal Concept]
  1000   C1442464:48 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.68: Staining of -synuclein transfected neurons for tau, which is axonal in distribution, with antibody TP70, revealed a co-distribution of -synuclein with tau (Fig. 1A, arrows), showing that -synuclein is located primarily in axons and proximal regions of dendrites in transfected cortical neurons (Fig. 1A, arrowheads). 

Phrase: "Staining of -synuclein transfected neurons for tau,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "which"

Phrase: "is"

Phrase: "axonal in distribution,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0004461:Axon [Cell Component]

Phrase: "with antibody TP70,"

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "a co-distribution of -synuclein with tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "located"

Phrase: "primarily in axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0004461:Axons [Cell Component]

Phrase: "and"

Phrase: "proximal regions of dendrites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "in transfected cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.69: View larger version (40K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(40K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.70: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.71: Distribution and transport of transfected -synuclein in neurons. 

Phrase: "Distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "transport of transfected -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.72: (A) Rat cortical neurons 5 DIV were transfected with wild-type (WT) -synuclein and fixed at intervals after glycerol shock. 

Phrase: "(A) Rat cortical neurons 5 DIV"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0021135:In Vitro [Intellectual Product]
   812   C1533691:in vitro [Qualitative Concept]
           vitro
   812   C2827718:In Vitro [Functional Concept]
   793   C0439228:days [Temporal Concept]
   760 E C0332173:/day [Temporal Concept]
   760 E C0439505:/day [Temporal Concept]

Phrase: "were"

Phrase: "transfected with wild-type (WT) -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "fixed at intervals"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0231441:Fixed [Finding]
   790   C0443218:Fixed [Qualitative Concept]
   790   C1272706:intervals [Temporal Concept]
   790   C2827483:Fixed [Body Substance]
   756 E C1552654:Interval [Idea or Concept]
   756 E C1552713:Interval [Intellectual Product]

Phrase: "after glycerol shock."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]
Processing 00000000.tx.73: Panels show the expression of exogenous -synuclein, detected with the 90 antibody, at 2.5 hours, 6 hours and 24 hours after glycerol shock. 

Phrase: "Panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the expression of exogenous -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "detected with the 90 antibody,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0439083:>90 [Quantitative Concept]
   760   C0439087:<90 [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "at 2.5 hours,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439227:hours [Temporal Concept]
   779 E C0564385:/hour [Quantitative Concept]

Phrase: "6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "24 hours after glycerol shock."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0439584:24 hours [Temporal Concept]
   806   C0456696:/24 hours [Temporal Concept]
   806   C1442770:24 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.74: Cells fixed at 6 hours after glycerol shock are double labelled with 90 (left) and the antibody to tau, TP70 (right). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "fixed at 6 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0231441:Fixed [Finding]
   770   C0439227:hours [Temporal Concept]
   770   C0443218:Fixed [Qualitative Concept]
   770   C2827483:Fixed [Body Substance]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "after glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "are"

Phrase: "double"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Double [Functional Concept]
  1000   C1705764:Double [Activity]
  1000   C1705765:Double [Qualitative Concept]

Phrase: "labelled with 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   756   C0181496:Label [Manufactured Object]
   756   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the antibody to tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "TP70"

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.75: Arrows indicate co-distribution of -synuclein and tau, arrowheads indicate dendritic extensions containing -synuclein. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "co-distribution of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "tau,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: "indicate"

Phrase: "dendritic extensions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C3157063:dendritic extension [Cell Function]
   861   C0231448:extensions [Functional Concept]
   827 E C1880641:Extension [Conceptual Entity]

Phrase: "containing -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.76: Scale bars, 50 m. 

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.77: (B) Rat cortical neurons (5 DIV) were transfected with wild-type -synuclein and labelled with 90 at 30 minute intervals from 3 hours to 6 hours after glycerol shock. 

Phrase: "(B) Rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(5 DIV"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1442466:5 Days [Temporal Concept]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "transfected with wild-type -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "labelled with 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   756   C0181496:Label [Manufactured Object]
   756   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at 30 minute intervals"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C1272706:intervals [Temporal Concept]
   793 E C1552654:Interval [Idea or Concept]
   793 E C1552713:Interval [Intellectual Product]
   734   C0456693:30 minute [Temporal Concept]

Phrase: "from 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "to 6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after glycerol shock."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]
Processing 00000000.tx.78: Neurons were either untreated (circles) or treated with the metabolic inhibitors sodium azide and 2-deoxy-D-glucose (triangles) between 3 hours and 3.5 hours after glycerol shock. 

Phrase: "Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "either untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332155:untreated [Finding]

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: "or"

Phrase: "treated with the metabolic inhibitors sodium azide"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   778   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   778   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   748   C0004492:azide [Chemical Viewed Structurally]
   748   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0311400:Metabolic [Functional Concept]
   748   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C1522326:Treated [Functional Concept]
   748   C1524026:Metabolic [Cell Function]
   748   C2707259:Metabolic [Clinical Attribute]
   714 E C1292734:TREAT [Functional Concept]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ")"

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "3.5 hours after glycerol shock."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1442460:3 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.79: Points represent mean distance travelled (in m) from the axon hilum  s.e.m.  

Phrase: "Points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean distance travelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0040802:travel [Daily or Recreational Activity]
   793   C1555670:travel [Idea or Concept]

Phrase: "("

Phrase: "in"

Phrase: "m) from the axon hilum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004461:Axon [Cell Component]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0929176:Hilum [Body Part, Organ, or Organ Component]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.80: To determine the overall rate of transport of human -synuclein in cortical neurons, we used a previously described assay that measures the bulk movement of transfected protein by analysing the distance travelled by the fluorescent front at set time points in fixed cells (Ackerley et al., 2000). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the overall rate of transport of human -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "in cortical neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "that"

Phrase: "measures"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]
  1000   C1879489:Measures [Functional Concept]

Phrase: "the bulk movement of transfected protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0026649:Movement [Organism Function]

Phrase: "by analysing"

Phrase: "the distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:Distance [Quantitative Concept]
   928 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by the fluorescent front"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205094:front [Spatial Concept]
   760   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   726   C0040802:travel [Daily or Recreational Activity]
   726   C1555670:travel [Idea or Concept]

Phrase: "at set time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "in fixed cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1253961:Fixed cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.81: This assay has been used successfully to measure axonal transport of both neurofilaments and tau protein (Ackerley et al., 2000; Utton et al., 2002; Brownlees et al., 2002). 

Phrase: "This assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "successfully to"

Phrase: "measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "axonal transport of both neurofilaments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0004462:Axonal Transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: "; Utton et al.,"

Phrase: "2002"

Phrase: "; Brownlees et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.82: At 3 hours, most transfected neurons exhibited a single, brightly fluorescent process that extended further than the other neurites, so 3 hours after glycerol shock was selected as the earliest time at which we could obtain a reliable and reproducible measure of -synuclein transport in neurons. 

Phrase: "At 3 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "most transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "a single, brightly fluorescent process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1184743:Process [Body Part, Organ, or Organ Component]
   812   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "extended"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231448:Extended [Functional Concept]
  1000   C0231449:Extended [Spatial Concept]
  1000   C0439792:extended [Spatial Concept]

Phrase: "further than the"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1517331:Further [Spatial Concept]
   756 E C0205108:far [Spatial Concept]

Phrase: "other neurites,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurites [Cell Component]

Phrase: "so"

Phrase: "3 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1442460:3 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "was"

Phrase: "selected as the earliest time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C3541383:Time [Temporal Concept]
   726   C1279919:Early [Temporal Concept]
   726   C1707391:Select [Activity]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "at which"

Phrase: "we"

Phrase: "could"

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a reliable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "reproducible measure of -synuclein transport in neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0178766:neuron transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]
Processing 00000000.tx.83: Wild-type -synuclein was transported a mean distance of 162 m from the axon hilum between 3 hours and 6 hours after glycerol shock, equivalent to an overall transport rate of 54 m hour1 during this time, equivalent to 1.3 mm day1. 

Phrase: "Wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "was"

Phrase: "transported"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "a mean distance of 162 m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012751:Distance [Quantitative Concept]
   753   C0444504:Mean [Quantitative Concept]
   753   C2347634:Mean [Quantitative Concept]
   753   C2348143:Mean [Quantitative Concept]

Phrase: "from the axon hilum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0929176:Hilum [Body Part, Organ, or Organ Component]

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "equivalent to an overall transport rate of 54 m hour1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205163:Equivalent [Qualitative Concept]
   739   C0439185:equivalent [Quantitative Concept]

Phrase: "during this time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "equivalent to 1.3 mm day1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205163:Equivalent [Qualitative Concept]
   753   C0439185:equivalent [Quantitative Concept]
Processing 00000000.tx.84: Treatment of -synuclein-transfected cultures with the metabolic inhibitors sodium azide and 2-deoxy-D-glucose for 30 minutes at 3 hours after glycerol shock reduced the rate of transport of -synuclein to 126 m hour1 (n=110) from 617 m hour1 (n=90) in untreated cells, measured between 3.5 hours and 4 hours after glycerol shock (Fig. 1B). 

Phrase: "Treatment of -synuclein-transfected cultures with the metabolic inhibitors sodium azide"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   738   C0010453:Cultures [Idea or Concept]
   704 E C0220814:culture [Functional Concept]
   704 E C0430400:Culture [Laboratory Procedure]
   704 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "2-deoxy-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0069851:dE-oxy [Amino Acid, Peptide, or Protein]

Phrase: "D-"

Phrase: "glucose for 30 minutes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "at 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the rate of transport of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "to 126 m hour1"

Phrase: "(n=110"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "from 617 m hour1"

Phrase: "(n=90"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439083:>90 [Quantitative Concept]
   861   C0439087:<90 [Quantitative Concept]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in untreated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "measured between 3.5 hours"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0439227:hours [Temporal Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "4 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292426:4 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.85: Removal of azide/deoxyglucose from the cultures resulted in a delayed recovery (1 hour) of the rate of -synuclein transport to that observed before treatment, showing that the reduced transport was not due to cell death. 

Phrase: "Removal of azide/deoxyglucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015252:Removal [Therapeutic or Preventive Procedure]
   770   C0728940:Removal [Therapeutic or Preventive Procedure]

Phrase: "from the cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "resulted in a delayed recovery"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205421:Delayed [Temporal Concept]
   760   C0237820:Recovery [Activity]
   760   C1555688:recovery [Idea or Concept]
   760   C2004454:Recovery [Organism Function]
   760   C3272602:Delayed [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "(1 hour"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1442450:1 Hour [Temporal Concept]
   861   C0439227:Hour [Temporal Concept]
   861   C0564385:/hour [Quantitative Concept]

Phrase: ")"

Phrase: "of the rate of -synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]

Phrase: "to that"

Phrase: "observed before treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1441672:Observed [Functional Concept]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the reduced transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "not due to cell death."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0007587:Cell Death [Cell Function]
   806   C0678226:Due to [Functional Concept]
           due
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1518422:Not [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.86: Thus, as we found previously for the axonal transport of neurofilaments, -synuclein transport is an energy-requiring process that is not due to passive diffusion (Ackerley et al., 2000). 

Phrase: "Thus,"

Phrase: "as"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "previously for the axonal transport of neurofilaments, -"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0004462:Axonal Transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0027834:neurofilaments [Cell Component]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "an energy-requiring process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "not due to passive diffusion"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0012222:Diffusion [Natural Phenomenon or Process]
   760   C1518422:Not [Functional Concept]
   760   C1696141:Diffusion [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.87: We could detect no differences between the subcellular localization or rate of transports of wild-type and mutant EGFP-tagged -synuclein constructs (in which EGFP was fused to the N-terminus of -synuclein) and their untagged counterparts. 

Phrase: "We"

Phrase: "could"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "no differences between the subcellular localization or rate of transports of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   702   C1705241:*Difference [Quantitative Concept]
   702   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "mutant EGFP-tagged -synuclein constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1171362:expression protein [Genetic Function]
   739   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "("

Phrase: "in which EGFP"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   864   C1171362:expression protein [Genetic Function]
   861   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   835   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   793   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   793   C0150312:In [Quantitative Concept]
   793   C0185117:Expression [Therapeutic or Preventive Procedure]
   793   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   793   C0332285:In [Spatial Concept]
   793   C0332583:Green [Qualitative Concept]
   793   C2349975:Enhanced [Activity]
   721 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "fused to the N-terminus of -synuclein"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0699952:Fused [Functional Concept]
   714 E C1414861:FUSE [Gene or Genome]
   714 E C1708111:Fuse [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "their untagged counterparts."
Processing 00000000.tx.88: However, human wild-type -synuclein expressed as a C-terminally tagged EGFP fusion protein aggregated in transfected rat cortical neurons, suggesting that addition of EGFP to the C-terminus of -synuclein has a deleterious effect on protein folding and resulting conformation in neurons (not shown). 

Phrase: "However,"

Phrase: "human wild-type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed"

Phrase: "as a C-terminally tagged EGFP fusion protein"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
   830   C1171362:expression protein [Genetic Function]
   822   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   809   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   797   C0162768:Fusion protein [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0185117:Expression [Therapeutic or Preventive Procedure]
   786   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   786   C0332466:Fusion [Functional Concept]
   786   C0332583:Green [Qualitative Concept]
   786   C1293131:Fusion [Therapeutic or Preventive Procedure]
   786   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   786   C1708632:Tagged [Qualitative Concept]
   786   C2349975:Enhanced [Activity]
   753 E C0037293:Tag [Neoplastic Process]
   753 E C0181496:Tag [Manufactured Object]
   753 E C1710492:TAG [Gene or Genome]
   715 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "aggregated in transfected rat cortical neurons,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0001613:Cortical [Body Part, Organ, or Organ Component]
   753   C0007776:Cortical [Body Part, Organ, or Organ Component]
   753   C0022655:Cortical [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0332621:Aggregated [Functional Concept]
   719 E C0205418:Aggregate [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that addition of EGFP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1883712:Addition [Functional Concept]

Phrase: "to the C-terminus of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "a deleterious effect on protein folding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "resulting conformation in neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026377:Conformation [Spatial Concept]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.89: Axonal transport of A30P and A53T -synuclein is reduced The distance travelled by A30P and A53T -synuclein by 6 hours after transfection into cortical neurons was lower than for the wild-type protein (Fig. 2A). 

Phrase: "Axonal transport of A30P"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "The distance"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:Distance [Quantitative Concept]
   928 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by A30P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0040802:travel [Daily or Recreational Activity]
   756   C1555670:travel [Idea or Concept]

Phrase: "and"

Phrase: "A53T -synuclein by 6 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "into cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0441994:Lower [Spatial Concept]
   833   C1548802:Lower [Body Location or Region]
   833   C2003888:Lower [Activity]

Phrase: "for the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.90: At 24 hours after glycerol shock, transfection of A30P -synuclein (unlike A53T and wild-type -synuclein) also resulted in the presence of large swellings filled with -synuclein proximal to the neuronal cell body in some neurons (Fig. 2A). 

Phrase: "At 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0439584:24 hours [Temporal Concept]
  1000   C0456696:/24 hours [Temporal Concept]
  1000   C1442770:24 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after glycerol shock,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "transfection of A30P -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "("

Phrase: "unlike A53T"

Phrase: "and"

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ")"

Phrase: "also"

Phrase: "resulted in the presence of large swellings"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0013604:swellings [Pathologic Function]
   748   C0038999:swellings [Finding]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0549177:Large [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "filled with -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1708059:Filled [Activity]

Phrase: "proximal to the neuronal cell body"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205107:Proximal [Spatial Concept]

Phrase: "in some neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.91: To determine whether there was a quantitative difference between the axonal transport of wild-type and the Parkinson's-disease-associated mutant -synucleins, we measured the distances travelled by A30P and A53T -synuclein between 3 hours and 6 hours after transfection (Fig. 2B). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "there"

Phrase: "was"

Phrase: "a quantitative difference between the axonal transport of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1705241:*Difference [Quantitative Concept]
   739   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "the Parkinson's-disease-associated mutant -synucleins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:distances [Quantitative Concept]
   916 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by A30P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0040802:travel [Daily or Recreational Activity]
   756   C1555670:travel [Idea or Concept]

Phrase: "and"

Phrase: "A53T -synuclein between 3 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "6 hours after transfection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292428:6 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.92: The distances travelled by each of the mutants were significantly reduced compared with the wild-type protein at 3, 4, 5 and 6 hours after glycerol shock (Fig. 2B, P<0.05). 

Phrase: "The distances"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0012751:distances [Quantitative Concept]
   916 E C0443203:Distant [Spatial Concept]

Phrase: "travelled by each of the mutants"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0596988:mutants [Cell or Molecular Dysfunction]
   719   C0040802:travel [Daily or Recreational Activity]
   719   C1555670:travel [Idea or Concept]

Phrase: "were"

Phrase: "significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with the wild-type protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]

Phrase: "at 3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 2B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: "P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.93: Both of the mutant -synuclein proteins travelled 140 m from the axon hilum by 6 hours, equivalent to a rate of 30 m hour1 or 0.7 mm day1 measured between 3 hours and 6 hours after glycerol shock. 

Phrase: "Both of the mutant -synuclein proteins"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1564139:Mutant Proteins [Amino Acid, Peptide, or Protein]
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0238767:Both [Spatial Concept]
   753   C0596988:Mutant [Cell or Molecular Dysfunction]
   753   C1706086:Both [Qualitative Concept]

Phrase: "travelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0040802:travel [Daily or Recreational Activity]
   966   C1555670:travel [Idea or Concept]

Phrase: "140 m from the axon hilum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0536753:M 140 [Organic Chemical,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]

Phrase: "by 6 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "equivalent to a rate of 30 m hour1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0205163:Equivalent [Qualitative Concept]
   744   C0439185:equivalent [Quantitative Concept]

Phrase: "or"

Phrase: "0.7 mm day1"

Phrase: "measured between 3 hours"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439227:hours [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.94: However, we observed that the rate of transport of wild-type and mutant -synuclein was not linear throughout the 3-hour observation time, so we examined the rates of transport of each construct at hourly intervals after glycerol shock (Fig. 2C). 

Phrase: "However,"

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the rate of transport of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not linear throughout the 3-hour observation time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0205132:Linear [Spatial Concept]

Phrase: "so"

Phrase: "we"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "the rates of transport of each construct"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "at hourly intervals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1272706:intervals [Temporal Concept]
   827 E C1552654:Interval [Idea or Concept]
   827 E C1552713:Interval [Intellectual Product]

Phrase: "after glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "(Fig. 2C"

Phrase: ")."
Processing 00000000.tx.95: We found that wild-type -synuclein was transported faster than both A30P and A53T -synuclein at 3-4 hours and 4-5 hours after glycerol shock, and this difference was statistically significant for both mutant proteins (P<0.001). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "was"

Phrase: "transported"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005528:Transport, NOS [Cell Function]
   966   C1317949:Transport [Manufactured Object]
   966   C3495449:transport [Medical Device]

Phrase: "faster than both A30P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "A53T -synuclein at 3-4 hours"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "4-5 hours after glycerol shock,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1292426:4 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "this difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1705241:*Difference [Quantitative Concept]
  1000   C1705242:Difference [Qualitative Concept]
   928 E C0443199:Differential [Qualitative Concept]

Phrase: "was"

Phrase: "statistically significant for both mutant proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0237881:statistically significant [Quantitative Concept]
           significant
   753   C0038215:Statistically [Occupation or Discipline]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   718 E C1709380:Statistical Significance [Quantitative Concept]

Phrase: "(P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.96: However, the transport rate of wild-type -synuclein was significantly decreased from 62 m hour1 at 3-4 hours after transfection to 45 m hour1 at 5-6 hours (P<0.05); 

Phrase: "However,"

Phrase: "the transport rate of wild-type -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005528:Transport, NOS [Cell Function]
   748   C0871208:Rate [Activity]
   748   C1317949:Transport [Manufactured Object]
   748   C1521828:Rate [Quantitative Concept]
   748   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "significantly"

Phrase: "decreased from 62 m hour1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0205216:Decreased [Quantitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0392756:Decreased [Qualitative Concept]
   760   C0441923:M+ [Intellectual Product]
   760   C0442797:decreased [Qualitative Concept]
   726 E C0547047:Decrease [Quantitative Concept]

Phrase: "at 3-4 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442460:3 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0442757:3 4 [Finding]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "to 45 m hour1"

Phrase: "at 5-6 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442467:5 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0442749:5 6 [Finding]

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.97: at this later time, the rates of transport of wild-type and mutant -synucleins were similar. 

Phrase: "at this later time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "the rates of transport of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "mutant -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "similar."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]
Processing 00000000.tx.98: This suggests that the most significant effects of the A30P and A53T mutations in -synuclein are exerted at the earlier time points and that, at 5-6 hours after transfection, the rates of mutant -synuclein transport recovers to such an extent that the effects of the mutations are reduced. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the most significant effects of the A30P"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "A53T mutations in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "exerted at the earlier time points"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C2348792:Time Point [Temporal Concept]
   753   C0015264:Exerted [Organism Function]
   753   C0040223:Time [Temporal Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1279919:Early [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "and"

Phrase: "that,"

Phrase: "at 5-6 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442467:5 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0442749:5 6 [Finding]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the rates of mutant -synuclein transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "recovers to such"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0521108:recover [Qualitative Concept]
   790   C2004454:recover [Organism Function]

Phrase: "an extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439792:Extent [Spatial Concept]

Phrase: "that"

Phrase: "the effects of the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "reduced."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.99: View larger version (28K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.101: -Synuclein mutants associated with Parkinson's disease exhibit reduced transport in neurons. 

Phrase: "-Synuclein mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "associated with Parkinson's disease exhibit reduced transport"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   778   C0030567:Parkinson Disease [Disease or Syndrome]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   778   C1521736:Parkinson's Disease [Functional Concept]
   778   C2681933:PARKINSON DISEASE [Gene or Genome]
   774   C0243083:associated disease [Pathologic Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0015272:Exhibit [Intellectual Product]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.102: (A) Rat primary neuronal cortical cultures were transfected at 5 DIV with wild-type (WT), A53T or A30P -synuclein and fixed 6 hours or 24 hours after transfection. 

Phrase: "(A) Rat primary neuronal cortical cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0010453:Cultures [Idea or Concept]
   766 E C0220814:culture [Functional Concept]
   766 E C0430400:Culture [Laboratory Procedure]
   766 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "transfected at 5 DIV"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0439228:days [Temporal Concept]
   719 E C0332173:/day [Temporal Concept]
   719 E C0439505:/day [Temporal Concept]

Phrase: "with wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A53T"

Phrase: "or"

Phrase: "A30P -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "6 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292428:6 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "or"

Phrase: "24 hours after transfection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0439584:24 hours [Temporal Concept]
   833   C0456696:/24 hours [Temporal Concept]
   833   C1442770:24 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.103: -Synuclein expression was detected with 90. 

Phrase: "-Synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected with 90."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.104: Arrows indicate the extent of -synuclein migration in the longest neurite extending from each neuron. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the extent of -synuclein migration in the longest neurite extending"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0600210:Migration [Social Behavior]
   739   C1533574:Migration [Physiologic Function]
   739   C1881827:MIGRATION [Phenomenon or Process]

Phrase: "from each neuron."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.105: Swellings containing A30P mutant -synuclein are indicated by arrowheads. 

Phrase: "Swellings"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0013604:swellings [Pathologic Function]
  1000   C0038999:swellings [Finding]
   900 E C1709317:Oncosis [Cell Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "A30P mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "indicated by arrowheads."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C1080898:Arrowheads [Plant]
   790   C1444656:Indicated [Finding]
   756 E C0453107:Arrowhead [Food]
Processing 00000000.tx.106: Scale bars, 50 m. 

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.107: (B) Human wild-type (circles), A30P (squares) and A53T (triangles) -synuclein were transfected into 5 DIV rat cortical cultures and labelled with 90 at 3 hours, 4 hours, 5 hours and 6 hours after glycerol shock. 

Phrase: "(B) Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086418:Human [Human]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: ")"

Phrase: ","

Phrase: "A30P"

Phrase: "(squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0205120:Square [Spatial Concept]
   966   C1552595:Square [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "A53T"

Phrase: "(triangles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205119:triangles [Conceptual Entity]

Phrase: ") -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transfected into 5 DIV rat cortical cultures"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0010453:Cultures [Idea or Concept]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0439228:days [Temporal Concept]
   708 E C0220814:culture [Functional Concept]
   708 E C0332173:/day [Temporal Concept]
   708 E C0430400:Culture [Laboratory Procedure]
   708 E C0439505:/day [Temporal Concept]
   708 E C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "labelled with 90"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   756   C0181496:Label [Manufactured Object]
   756   C2827499:Label [Governmental or Regulatory Activity]

Phrase: "at 3 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "4 hours,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292426:4 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "5 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442467:5 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.108: Points represent mean distance travelled (in m) from the axon hilum  s.e.m. 

Phrase: "Points"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1552961:Point [Quantitative Concept]
   966   C2347617:point [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean distance travelled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0040802:travel [Daily or Recreational Activity]
   793   C1555670:travel [Idea or Concept]

Phrase: "("

Phrase: "in"

Phrase: "m) from the axon hilum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004461:Axon [Cell Component]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C0929176:Hilum [Body Part, Organ, or Organ Component]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.109: The differences between the distances moved by wild-type and mutant -synucleins were statistically significant at each time point examined [P<0.05 at 3 hours, P<0.01 at 4 hours, 5 hours and 6 hours after glycerol shock (n=40-124 neurons)]. 

Phrase: "The differences between the distances"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1705241:*Difference [Quantitative Concept]
   726   C1705242:Difference [Qualitative Concept]

Phrase: "moved by wild-type"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1269909:moved [Functional Concept]
   770   C1299988:moved [Functional Concept]
   770   C1547052:*Type [Quantitative Concept]
   770   C2699029:Moved [Activity]
   737 E C0560560:move [Organism Function]
   737 E C0578671:move [Finding]

Phrase: "and"

Phrase: "mutant -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "statistically significant at each time point"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0237881:statistically significant [Quantitative Concept]
           significant
   753   C0038215:Statistically [Occupation or Discipline]
   753   C0750502:Significant [Idea or Concept]
   753   C1546944:Significant [Qualitative Concept]
   718 E C1709380:Statistical Significance [Quantitative Concept]

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "[P<0.05 at 3 hours,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439227:hours [Temporal Concept]
   753   C2603361:P' [Clinical Attribute]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "P<0.01 at 4 hours,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439227:hours [Temporal Concept]
   753   C2603361:P' [Clinical Attribute]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "5 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442467:5 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(n=40-124 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "]."
Processing 00000000.tx.110: (C) -Synuclein was transfected into 5 DIV rat cortical cultures as above and rates of transport were calculated at hourly intervals during the time of observation. 

Phrase: "(C) -Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "transfected into 5 DIV rat cortical cultures"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0010453:Cultures [Idea or Concept]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0439228:days [Temporal Concept]
   708 E C0220814:culture [Functional Concept]
   708 E C0332173:/day [Temporal Concept]
   708 E C0430400:Culture [Laboratory Procedure]
   708 E C0439505:/day [Temporal Concept]
   708 E C2242979:Culture [Laboratory Procedure]

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "and"

Phrase: "rates of transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "calculated at hourly intervals"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C0558292:Hourly [Temporal Concept]
   770   C1272706:intervals [Temporal Concept]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   737 E C1552654:Interval [Idea or Concept]
   737 E C1552713:Interval [Intellectual Product]

Phrase: "during the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of observation."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.111: Bars show mean rates  s.e.m. for wild-type (black), A30P (white) and A53T (grey) -synuclein. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "mean rates"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0444504:Mean [Quantitative Concept]
   861   C2347634:Mean [Quantitative Concept]
   861   C2348143:Mean [Quantitative Concept]
   827   C0871208:Rate [Activity]
   827   C1521828:Rate [Quantitative Concept]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "for wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A30P"

Phrase: "(white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "A53T"

Phrase: "(grey"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ") -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.112: *P<0.001 compared with wild-type -synuclein. 

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with wild-type -synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.113: (D) Rat cortical neurons were transfected with human -synuclein plasmids, fixed 4 hours after glycerol shock and labelled with 90. 

Phrase: "("

Phrase: "D)"

Phrase: "Rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "transfected with human -synuclein plasmids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0086418:Human [Human]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "4 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292426:4 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "labelled with 90."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439083:>90 [Quantitative Concept]
   790   C0439087:<90 [Quantitative Concept]
   756   C0181496:Label [Manufactured Object]
   756   C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.114: The average intensity of immunofluorescence within the neuronal cell body was measured for wild-type (n=96 neurons), A30P (n=138 neurons), and A53T (n=82 neurons) -synuclein. 

Phrase: "The average intensity of immunofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "within the neuronal cell body"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0599444:neuronal cell body [Cell Component]
           Cell body
   901   C2752549:cell body [Cell Component]
   877   C0682679:neuron body [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "was"

Phrase: "measured for wild-type"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   833   C1883559:Wild Type [Organism Attribute]
   770   C0332307:Type [Qualitative Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C0445392:Wild [Intellectual Product]
   770   C1547052:*Type [Quantitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(n=96 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "A30P"

Phrase: "(n=138 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "A53T"

Phrase: "(n=82 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ") -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.115: The asterisk indicates P<0.05 for A30P -synuclein average immunofluorescence intensity compared with the wild type. 

Phrase: "The asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "indicates"

Phrase: "P<0.05 for A30P -synuclein average immunofluorescence intensity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0016318:Immunofluorescence [Laboratory Procedure]
   742   C0079603:Immunofluorescence [Laboratory Procedure]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0522510:Intensity [Qualitative Concept]
   742   C1510992:Average [Quantitative Concept]
   742   C2603361:P' [Clinical Attribute]
   742   C2825518:AVERAGE [Quantitative Concept]

Phrase: "compared with the wild type."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.116: Bars represent mean intensity of immunofluorescence  s.e.m.  

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean intensity of immunofluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0444504:Mean [Quantitative Concept]
   770   C0522510:Intensity [Qualitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.117: Because the amounts of -synuclein expressed by the wild-type, A30P and A53T -synuclein constructs might influence their relative rates of transport in neurons, we measured the intensity of immunofluorescence as a measure of the amount of each exogenously expressed protein in the neuronal cell body at 4 hours after transfection. 

Phrase: "Because"

Phrase: "the amounts of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "expressed by the wild-type, A30P"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A53T -synuclein constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2827421:Construct [Classification]

Phrase: "might"

Phrase: "influence"

Phrase: "their relative rates of transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0080103:Relative [Family Group]
   760   C0205345:Relative [Qualitative Concept]
   760   C1547039:*Relative [Quantitative Concept]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "in neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "we"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "the intensity of immunofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "as a measure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079809:Measure [Quantitative Concept]
  1000   C0242485:Measure [Functional Concept]

Phrase: "of the amount"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1265611:Amount [Quantitative Concept]

Phrase: "of each exogenously expressed protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the neuronal cell body"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0599444:neuronal cell body [Cell Component]
           Cell body
   901   C2752549:cell body [Cell Component]
   877   C0682679:neuron body [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   743 E C1995017:Bodies [Cell Component]

Phrase: "at 4 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1292426:4 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.118: We found that neurons transfected with the plasmid expressing A30P -synuclein exhibited more immunofluorescence than those expressing wild-type or A53T -synuclein at this time (Fig. 2D, *P<0.05). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "transfected with the plasmid expressing A30P -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "more immunofluorescence than those expressing wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0016318:Immunofluorescence [Laboratory Procedure]
   748   C0079603:Immunofluorescence [Laboratory Procedure]

Phrase: "or"

Phrase: "A53T -synuclein at this time"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 2D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1705052:2D [Spatial Concept]
   861   C2986796:2D [Functional Concept]

Phrase: "*P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.119: A53T -synuclein exhibits reduced axonal transport and both wild-type and A53T -synuclein are expressed in equal amounts, which suggests that the decreased transport of A53T -synuclein is not due to altered expression or turnover of the mutant protein. 

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "reduced axonal transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0004462:Axonal Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   755   C0004461:Axon [Cell Component]

Phrase: "and"

Phrase: "both wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "expressed in equal amounts,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205163:Equal [Qualitative Concept]
   770   C1265611:amounts [Quantitative Concept]
   770   C1549782:Equal [Idea or Concept]

Phrase: "which"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the decreased transport of A53T -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "not due to altered expression"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C0392747:Altered [Functional Concept]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "or"

Phrase: "turnover of the mutant protein."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0597297:Protein Turnover [Molecular Function]
   760   C0031227:turnover [Quantitative Concept]
   760   C0243127:turnover [Functional Concept]
   760   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.120: Furthermore, because the amount of cellular A30P -synuclein was increased and transport of A30P -synuclein was decreased compared with the wild type, the neuronal inclusions observed after A30P -synuclein expression might be caused by a combination of decreased metabolism and/or reduced transport of this mutant form of the protein leading to an increased cellular concentration of -synuclein. 

Phrase: "Furthermore,"

Phrase: "because"

Phrase: "the amount of cellular A30P -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "transport of A30P -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "compared with the wild type,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "the neuronal inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512693:Inclusion [Qualitative Concept]

Phrase: "observed after A30P -synuclein expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
   760   C1441672:Observed [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "caused by a combination of decreased metabolism"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0025519:Metabolism [Organism Function]
   748   C0025520:metabolism [Functional Concept]
   748   C0205195:Combination [Qualitative Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1947911:Combination [Physical Object]
   714   C0015127:cause [Functional Concept]
   714 E C0547047:Decrease [Quantitative Concept]
   714   C1524003:Cause [Conceptual Entity]

Phrase: "and/or"

Phrase: "reduced transport of this mutant form of the protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0599895:protein transport [Cell Function]
   762   C1159772:Protein Transport [Cell Function]
   742   C0005528:Transport, NOS [Cell Function]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]

Phrase: "leading to an increased cellular concentration of -synuclein."
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   750   C0861064:increased lead [Finding]
   744   C0007634:Cellular [Cell]
   744   C0086045:Concentration [Mental Process]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0178539:Cellular [Functional Concept]
   744   C0205217:Increased [Quantitative Concept]
   744   C0332152:Leading [Temporal Concept]
   744   C0442805:Increased [Functional Concept]
   744   C1446561:Concentration [Quantitative Concept]
   744   C1522538:Leading [Functional Concept]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.121: Cycloheximide treatment of neurons transfected with wild-type -synuclein at 3.5 hours after glycerol shock failed to affect -synuclein transport (not shown), showing that reducing -synuclein synthesis in neurons does not inhibit its transport. 

Phrase: "Cycloheximide treatment of neurons"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "transfected with wild-type -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]

Phrase: "at 3.5 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1442460:3 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0442758:3 5 [Quantitative Concept]

Phrase: "after glycerol shock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036974:Shock [Pathologic Function]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that reducing -synuclein synthesis in neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "its transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]
Processing 00000000.tx.122: Taken together, these results suggest that the reduced transport of A30P and A53T -synuclein that we observed in neurons is not due to altered levels of protein expression. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the reduced transport of A30P"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "A53T -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "we"

Phrase: "observed in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1441672:Observed [Functional Concept]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "is"

Phrase: "not due to altered levels of protein expression."
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   770   C0678226:Due to [Functional Concept]
           due
   770   C1171362:protein expression [Genetic Function]
   750   C0428479:Protein level [Laboratory or Test Result]
   750   C3244092:expression level [Idea or Concept]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0392747:Altered [Functional Concept]
   744   C0441889:Levels [Qualitative Concept]
   744   C1518422:Not [Functional Concept]
   744   C3146286:Due [Idea or Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.123: The calcium phosphate transfection protocol used for primary neuronal cultures compromises the viability of a small proportion of neurons, but we found no significant differences between the viability of neurons expressing exogenous wild-type or mutant -synucleins (not shown). 

Phrase: "The calcium phosphate transfection protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0442711:Protocol [Intellectual Product]
   812   C1507394:Protocol [Intellectual Product]
   812   C1522729:Protocol [Intellectual Product]
   812   C2348563:Protocol [Intellectual Product]

Phrase: "used for primary neuronal cultures"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   760   C0010453:Cultures [Idea or Concept]
   760   C0205225:Primary [Qualitative Concept]
   760   C0439631:Primary [Therapeutic or Preventive Procedure]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
   726 E C2242979:Culture [Laboratory Procedure]

Phrase: "compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "the viability of a small proportion of neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0443348:viability [Qualitative Concept]

Phrase: "but"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no significant differences between the viability of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "expressing"

Phrase: "exogenous wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1883559:Wild Type [Organism Attribute]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: Furthermore, transport measurements were made only on neurons with a normal cellular morphology and bis-benzimide staining was used to exclude any neurons with nuclear abnormalities. 

Phrase: "Furthermore,"

Phrase: "transport measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "only on neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0027882:Neurons [Cell]
   790   C0205171:Only [Quantitative Concept]
   790   C1720467:Only [Intellectual Product]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "with a normal cellular morphology"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0586628:Normal cellular morphology [Finding]
   901   C0243091:cellular morphology [Qualitative Concept]
   901   C1521816:Cellular Morphology [Clinical Attribute]
   901   C2700385:Cellular Morphology [Biomedical Occupation or Discipline]
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "bis-benzimide staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "any neurons with nuclear abnormalities."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027882:Neurons [Cell]
   756   C1441012:Neuronal nuclear [Immunologic Factor]
Processing 00000000.tx.125: Thus, the reduced transport of A30P and A53T mutant -synucleins was not accounted for by impaired cell viability. 

Phrase: "Thus,"

Phrase: "the reduced transport of A30P"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "A53T mutant -synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by impaired cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0007620:Cell Viability [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0443348:viability [Qualitative Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.126: To address any potential toxic effect of mutant -synuclein relative to the wild-type protein in rat cortical neurons that might affect axonal transport more generally, we also investigated the distribution of mitochondria in transfected neurons. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "any potential toxic effect of mutant -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   774   C0243169:toxic potential [Quantitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1407029:Toxic [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "relative to the wild-type protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in rat cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "might"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "axonal transport more generally,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0004462:Axonal Transport [Cell Function]
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
   741   C0004461:Axon [Cell Component]

Phrase: "we also"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the distribution of mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   909   C1522855:distribution of mitochondria [Cell Function]
           mitochondrion distribution
   770   C0520511:distribution [Idea or Concept]
   770   C1704711:Distribution [Functional Concept]

Phrase: "in transfected neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.127: A plasmid expressing the targeting sequence from subunit VIII of cytochrome c oxidase tagged with the fluorescent protein DsRed2 was transfected into neurons as a mitochondrial marker. 

Phrase: "A plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the targeting sequence from subunit VIII of cytochrome c oxidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "tagged with the fluorescent protein DsRed2"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   767   C1818826:protein tag [Molecular Function]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   753   C1708632:Tagged [Qualitative Concept]
   719 E C0037293:Tag [Neoplastic Process]
   719 E C0181496:Tag [Manufactured Object]
   719 E C1710492:TAG [Gene or Genome]

Phrase: "was"

Phrase: "transfected into neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as a mitochondrial marker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005516:Marker [Clinical Attribute]
Processing 00000000.tx.128: The distribution of the tagged mitochondria was detected by direct fluorescence of DsRed2 in neurons 24 hours after transfection (Fig. 3, MITO). 

Phrase: "The distribution of the tagged mitochondria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   820   C1522855:distribution of mitochondria [Cell Function]
           mitochondrion distribution
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "detected by direct fluorescence of DsRed2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0439851:Direct [Qualitative Concept]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1947931:Direct [Qualitative Concept]

Phrase: "in neurons 24 hours"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0439584:24 hours [Temporal Concept]
   901   C0456696:/24 hours [Temporal Concept]
   901   C1442770:24 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "MITO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002475:MITO [Antibiotic,Organic Chemical]
  1000   C1624538:mito [Plant]

Phrase: ")."
Processing 00000000.tx.129: Co-transfection of the mitochondrial marker plasmid with -synuclein into neurons revealed no differences between the distribution of mitochondria in cells expressing wild-type or mutant A30P -synuclein (Fig. 3). 

Phrase: "Co-transfection of the mitochondrial marker plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "with -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "into neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "no differences between the distribution of mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C1705241:*Difference [Quantitative Concept]
   714   C1705242:Difference [Qualitative Concept]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "mutant A30P -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.130: These results show that expression of -synuclein apparently does not have a generalized deleterious effect on axonal transport of organelles in neurons and that the reduced transport of A30P -synuclein is therefore unlikely to be due to a toxic effect on the cells that compromises their normal transport functions. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that expression of -synuclein apparently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "a generalized deleterious effect on axonal transport of organelles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "that"

Phrase: "the reduced transport of A30P -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "therefore unlikely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0750558:Unlikely [Conceptual Entity]
   827   C1710571:Unlikely [Qualitative Concept]

Phrase: "be due to a toxic effect"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0600688:Toxic effect [Injury or Poisoning]
           toxic
   790   C0678226:Due to [Functional Concept]
           due
   753   C1280500:Effect [Qualitative Concept]
   753   C1407029:Toxic [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]
   753   C2987476:Be [Conceptual Entity]
   753   C3146286:Due [Idea or Concept]

Phrase: "on the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "compromises"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "their normal transport functions."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.131: View larger version (39K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.132: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.133: -Synuclein expression does not perturb axonal transport of mitochondria in rat cortical neurons. 

Phrase: "-Synuclein expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "perturb"

Phrase: "axonal transport of mitochondria"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   982   C1156036:axon transport of mitochondria [Cell Function]
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in rat cortical neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.134: Rat primary neuronal cortical cultures (5 DIV) were transfected with a plasmid expressing the targeting sequence from subunit VIII of cytochrome c oxidase tagged with DsRed2 (MITO) or co-transfected with the mitochondrial marker plus EGFP-tagged wild-type (WT) or A30P mutant -synuclein (A30P), and fixed 24 hours after transfection. 

Phrase: "Rat primary neuronal cortical cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0010453:Cultures [Idea or Concept]
   771 E C0220814:culture [Functional Concept]
   771 E C0430400:Culture [Laboratory Procedure]
   771 E C2242979:Culture [Laboratory Procedure]

Phrase: "(5 DIV"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1442466:5 Days [Temporal Concept]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "were"

Phrase: "transfected with a plasmid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the targeting sequence from subunit VIII of cytochrome c oxidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C1519249:Sequence [Functional Concept]

Phrase: "tagged with DsRed2"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   790   C1708632:Tagged [Qualitative Concept]
   756 E C0037293:Tag [Neoplastic Process]
   756 E C0181496:Tag [Manufactured Object]
   756 E C1710492:TAG [Gene or Genome]

Phrase: "(MITO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002475:MITO [Antibiotic,Organic Chemical]
  1000   C1624538:mito [Plant]

Phrase: ")"

Phrase: "or"

Phrase: "co-transfected"

Phrase: "with the mitochondrial marker plus EGFP-tagged wild-type"
Meta Candidates (Total=27; Excluded=4; Pruned=0; Remaining=23)
   890   C0332307:With type [Qualitative Concept]
           Type
   850   C0949610:Mitochondrial Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   826   C1171362:expression protein [Genetic Function]
   818   C1258415:enhanced green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   806   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   795   C1883559:Wild Type [Organism Attribute]
   786   C0005516:Marker [Clinical Attribute]
   786   C0026237:Mitochondrial [Cell Component]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0185117:Expression [Therapeutic or Preventive Procedure]
   786   C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   786   C0332287:Plus [Qualitative Concept]
           With
   786   C0332583:Green [Qualitative Concept]
   786   C0445392:Wild [Intellectual Product]
   786   C0521451:Mitochondrial [Functional Concept]
   786   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   786   C1547052:*Type [Quantitative Concept]
   786   C1705690:With [Intellectual Product]
   786   C1708632:Tagged [Qualitative Concept]
   786   C2349975:Enhanced [Activity]
   779   C1818826:protein tag [Molecular Function]
   752 E C0037293:Tag [Neoplastic Process]
   752 E C0181496:Tag [Manufactured Object]
   752 E C1710492:TAG [Gene or Genome]
   714 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "A30P mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(A30P"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "fixed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0231441:Fixed [Finding]
  1000   C0443218:Fixed [Qualitative Concept]
  1000   C2827483:Fixed [Body Substance]

Phrase: "24 hours after transfection."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0439584:24 hours [Temporal Concept]
   833   C0456696:/24 hours [Temporal Concept]
   833   C1442770:24 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.135: Protein expression was detected by direct fluorescence of DsRed2-cytochrome c oxidase (MITO), EGFP-tagged wild-type (WT) or A30P mutant (A30P) -synuclein. 

Phrase: "Protein expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1171362:protein expression [Genetic Function]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "detected by direct fluorescence of DsRed2-cytochrome c oxidase"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   790   C0010760:CYTOCHROME C OXIDASE [Amino Acid, Peptide, or Protein,Enzyme]
           Cytochrome Oxidase
   764   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   764   C1153524:cytochrome c [Molecular Function]
   764   C1426584:CYTOCHROME C [Gene or Genome]
   742   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0242417:Oxidase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0439851:Direct [Qualitative Concept]
   742   C0442726:Detected [Finding]
   742   C1325304:cytochrome [Molecular Function]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1947931:Direct [Qualitative Concept]

Phrase: "(MITO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002475:MITO [Antibiotic,Organic Chemical]
  1000   C1624538:mito [Plant]

Phrase: ")"

Phrase: ","

Phrase: "EGFP-tagged wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C1171362:expression protein [Genetic Function]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(WT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: ")"

Phrase: "or"

Phrase: "A30P mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "(A30P"

Phrase: ") -"

Phrase: "synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.136: Scale bar, 50 m.  

Phrase: "Scale bar,"

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.137: Phosphorylation mimics of Ser87 or Ser129 reduce -synuclein transport in neurons To investigate serine phosphorylation in -synuclein as a possible mechanism involved in regulation of -synuclein transport, plasmids expressing the following mutants were transfected into rat cortical neurons: serine residues 87 and 129 of human -synuclein were individually mutated to mimic permanent states of phosphorylation (S87D and S129D) or dephosphorylation (S87A and S129A). 

Phrase: "Phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]

Phrase: "mimics of Ser87"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0393040:mimics [Therapeutic or Preventive Procedure]
   790   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "or"

Phrase: "Ser129"

Phrase: "reduce -"

Phrase: "synuclein transport in neurons To"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1550030:Transport To [Idea or Concept]
   781   C0178766:neuron transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "serine phosphorylation in -synuclein as a possible mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in regulation of -synuclein transport,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   820   C1523074:regulation of transport [Cell Function]
   753   C0005528:Transport, NOS [Cell Function]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1314939:Involved [Functional Concept]
   753   C1317949:Transport [Manufactured Object]
   753   C1327622:Regulation [Biologic Function]
   753   C3495449:transport [Medical Device]

Phrase: "plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "the following mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "transfected into rat cortical neurons"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]

Phrase: ":"

Phrase: "serine residues 87"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "129 of human -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0086418:Human [Human]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "individually"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "permanent states of phosphorylation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1301808:states [Geographic Area]
   737 E C1442792:State [Functional Concept]
   737 E C3148680:State [Geographic Area]

Phrase: "(S87D"

Phrase: "and"

Phrase: "S129D"

Phrase: ")"

Phrase: "or"

Phrase: "dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "(S87A"

Phrase: "and"

Phrase: "S129A"

Phrase: ")."
Processing 00000000.tx.138: There are now many examples in which introducing a charged residue accurately mimics the functional effect of phosphorylation of the protein (Leger et al., 1997; Antonsson et al., 1998). 

Phrase: "There"

Phrase: "are"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "many examples in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1707959:Example [Conceptual Entity]

Phrase: "introducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "a charged residue accurately"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   755 E C1609982:Residual [Qualitative Concept]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "the functional effect of phosphorylation of the protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "(Leger et al.,"

Phrase: "1997"

Phrase: "; Antonsson et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.139: Measured between 3 hours and 6 hours after glycerol shock, S87D -synuclein migrated at a rate of 312 m hour1 (n=124) and S129D -synuclein at 404 m hour1 (n=56), compared with 542 m hour1 (n=124) travelled by the wild-type protein. 

Phrase: "Measured between 3 hours"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439227:hours [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "S87D -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated at a rate of 312 m hour1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0232902:Migrated [Functional Concept]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441923:M+ [Intellectual Product]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]

Phrase: "(n=124"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "S129D -synuclein at 404 m hour1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(n=56"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "compared with 542 m hour1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1707455:Compared [Activity]

Phrase: "(n=124"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "travelled by the wild-type protein."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   719   C0040802:travel [Daily or Recreational Activity]
   719   C1555670:travel [Idea or Concept]
Processing 00000000.tx.140: Hence, the transport of S87D was reduced by 43% and S129D transport by 26%, and both of these reductions were statistically significant compared with the movement of wild-type -synuclein (Fig. 4, *P<0.001). 

Phrase: "Hence,"

Phrase: "the transport of S87D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "reduced by 43%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "S129D transport by 26%,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "both of these reductions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0238767:Both [Spatial Concept]
   770   C0301630:reductions [Natural Phenomenon or Process]
   770   C0441610:reductions [Therapeutic or Preventive Procedure]
   770   C1706086:Both [Qualitative Concept]
   737 E C0392756:Reduction [Qualitative Concept]

Phrase: "were"

Phrase: "statistically significant"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0237881:statistically significant [Quantitative Concept]
           significant
   928 E C1709380:Statistical Significance [Quantitative Concept]
   861   C0038215:Statistically [Occupation or Discipline]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "compared with the movement of wild-type -synuclein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1883559:Wild Type [Organism Attribute]
   744   C0026649:Movement [Organism Function]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332307:Type [Qualitative Concept]
   744   C0445392:Wild [Intellectual Product]
   744   C1547052:*Type [Quantitative Concept]
   744   C1707455:Compared [Activity]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.141: By contrast, both S87A and S129A -synuclein migrated at rates similar to the wild-type protein between 3 hours and 6 hours after glycerol shock (523 m hour1, n=53, and 494 m hour1, n=50, for S87A and S129A, respectively, P>0.05). 

Phrase: "By contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "both S87A"

Phrase: "and"

Phrase: "S129A -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "migrated at rates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0232902:Migrated [Functional Concept]
   756   C0871208:Rate [Activity]
   756   C1521828:Rate [Quantitative Concept]

Phrase: "similar to the wild-type protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348205:Similar [Qualitative Concept]

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "(523 m hour1,"

Phrase: "n=53,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "494 m hour1,"

Phrase: "n=50,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "for S87A"

Phrase: "and"

Phrase: "S129A,"

Phrase: "respectively,"

Phrase: "P>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.142: Hence, mimicking -synuclein phosphorylation by replacing either S87 or S129 with aspartate reduces its rate of axonal transport but, by contrast, inhibiting phosphorylation at these sites by mutating serine to the non-phosphorylatable residue alanine does not appear to alter -synuclein transport. 

Phrase: "Hence,"

Phrase: "mimicking -"

Phrase: "synuclein phosphorylation by replacing either S87"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "or"

Phrase: "S129 with aspartate"

Phrase: "reduces"

Phrase: "its rate of axonal transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "but"

Phrase: ","

Phrase: "by contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "phosphorylation at these sites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   802   C1519063:Phosphorylation Site [Amino Acid Sequence]
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "by mutating serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "to the non-phosphorylatable residue alanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "synuclein transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
Processing 00000000.tx.143: Physiological phosphorylation of S87 and/or S129 in neurons might therefore have a role in the regulation of -synuclein axonal transport. 

Phrase: "Physiological phosphorylation of S87"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "and/or"

Phrase: "S129 in neurons"

Phrase: "might"

Phrase: "therefore"

Phrase: "have"

Phrase: "a role in the regulation of -synuclein axonal transport."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0035820:Role [Social Behavior]
   742   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.144: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.145: 4. 

Phrase: "4."
Processing 00000000.tx.146: Mutants that mimic permanent serine phosphorylation of -synuclein exhibit reduced transport in rat cortical neurons. 

Phrase: "Mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "mimic"

Phrase: "permanent serine phosphorylation of -synuclein exhibit reduced transport in rat cortical neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   751   C1819242:serine transport [Cell Function]
   736   C0005528:Transport, NOS [Cell Function]
   736   C1317949:Transport [Manufactured Object]
   736   C3495449:transport [Medical Device]
   734   C0178766:neuron transport [Cell Function]
Processing 00000000.tx.147: -Synuclein mutants that mimic permanent states of phosphorylation (S87D, n=124 neurons, and S129D, n=56 neurons) or dephosphorylation (S87A, n=50 neurons, and S129A, n=53 neurons) of human -synuclein, or wild-type human -synuclein (WT, n=124 neurons) were transfected into 5 DIV rat cortical neurons. 

Phrase: "-Synuclein mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "mimic"

Phrase: "permanent states of phosphorylation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1301808:states [Geographic Area]
   737 E C1442792:State [Functional Concept]
   737 E C3148680:State [Geographic Area]

Phrase: "(S87D,"

Phrase: "n=124 neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "S129D,"

Phrase: "n=56 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "or"

Phrase: "dephosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1158884:Dephosphorylation [Molecular Function]
  1000   C3160734:Dephosphorylation [Molecular Function]

Phrase: "(S87A,"

Phrase: "n=50 neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "S129A,"

Phrase: "n=53 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "of human -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "wild-type human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(WT, n=124 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0027882:Neurons [Cell]
   721 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")"

Phrase: "were"

Phrase: "transfected into 5 DIV rat cortical neurons."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0439228:days [Temporal Concept]
   708 E C0332173:/day [Temporal Concept]
   708 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.148: Bars represent mean rate of transport (m hour1)  s.e.m. for each protein between 3 hours and 6 hours after glycerol shock. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "mean rate of transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444504:Mean [Quantitative Concept]
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "(m hour1"

Phrase: ")"

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "for each protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after glycerol shock."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   806   C1292428:6 Hours [Temporal Concept]
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]
Processing 00000000.tx.149: Transfection of the phosphorylation mimics of -synuclein, S87D or S129D, resulted in statistically significant reductions in the rate of transport compared to wild-type -synuclein (*P<0.001).  

Phrase: "Transfection of the phosphorylation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "mimics"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0393040:mimics [Therapeutic or Preventive Procedure]
  1000   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "S87D"

Phrase: "or"

Phrase: "S129D,"

Phrase: "resulted in statistically significant reductions"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0237881:statistically significant [Quantitative Concept]
           significant
   760   C0038215:Statistically [Occupation or Discipline]
   760   C0301630:reductions [Natural Phenomenon or Process]
   760   C0441610:reductions [Therapeutic or Preventive Procedure]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   735 E C1709380:Statistical Significance [Quantitative Concept]
   726 E C0392756:Reduction [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005528:Transport, NOS [Cell Function]
  1000   C1317949:Transport [Manufactured Object]
  1000   C3495449:transport [Medical Device]

Phrase: "compared to wild-type -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "("

Phrase: "*P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.150: Mutation of Y125 does not affect -synuclein transport in neurons Because -synuclein has also been demonstrated to be phosphorylated on tyrosine residues, we investigated the potential role of phosphorylation at Y125 to regulate axonal transport of -synuclein. 

Phrase: "Mutation of Y125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026882:Mutation [Genetic Function]
   790   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "synuclein transport in neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C0178766:neuron transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "Because -"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "phosphorylated on tyrosine residues,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   737   C1709915:Residue [Conceptual Entity]
   737   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the potential role of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "at Y125 to"

Phrase: "regulate"

Phrase: "axonal transport of -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.151: We either replaced Y125 with aspartate (Y125D) to mimic permanent phosphorylation or with phenylalanine (Y129F) to mimic permanent dephosphorylation, and each of these constructs was transfected into rat cortical neurons. 

Phrase: "We either replaced Y125 with aspartate"

Phrase: "(Y125D"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "permanent phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "or with phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(Y129F"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mimic"

Phrase: "permanent dephosphorylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1158884:Dephosphorylation [Molecular Function]
   861   C3160734:Dephosphorylation [Molecular Function]

Phrase: "and"

Phrase: "each of these constructs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457900:Each [Quantitative Concept]
   737   C2827421:Construct [Classification]

Phrase: "was"

Phrase: "transfected into rat cortical neurons."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0001613:Cortical [Body Part, Organ, or Organ Component]
   760   C0007776:Cortical [Body Part, Organ, or Organ Component]
   760   C0022655:Cortical [Body Part, Organ, or Organ Component]
   760   C0027882:Neurons [Cell]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   704 E C0234875:bark [Organism Attribute]
   704 E C2700441:Bark [Plant]
Processing 00000000.tx.152: The distributions of the tyrosine mutants Y125D and Y125F in rat cortical neurons were identical to the wild-type protein at all time points examined between 3 hours and 6 hours after transfection (Fig. 5A, 4.5 hours). 

Phrase: "The distributions of the tyrosine mutants Y125D"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0037775:Distributions [Spatial Concept]
   714 E C0520511:distribution [Idea or Concept]
   714 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "Y125F in rat cortical neurons"

Phrase: "were"

Phrase: "identical to the wild-type protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205280:Identical [Qualitative Concept]

Phrase: "at all time points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C2348792:Time Point [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "examined between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0332128:Examined [Finding]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after transfection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292428:6 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "4.5 hours"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C1292426:4 Hours [Temporal Concept]
   827   C0439227:hours [Temporal Concept]
   793 E C0564385:/hour [Quantitative Concept]
   734   C0450367:4 5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.153: The rates of transport of Y125D, Y129F and wild-type -synuclein measured between 3 hours and 4.5 hours after glycerol shock were 49 m hour1, 56 m hour1, and 51 m hour1, respectively, and the rates were also not significantly different at other intervals between 3 hours and 6 hours after transfection, demonstrating that the tyrosine mutants moved at the same rate as wild-type -synuclein (Fig. 5B, P>0.05). 

Phrase: "The rates of transport of Y125D,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "Y129F"

Phrase: "and"

Phrase: "wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "measured between 3 hours"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0439227:hours [Temporal Concept]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "4.5 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1292426:4 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "were"

Phrase: "49 m hour1,"

Phrase: "56 m hour1,"

Phrase: "and"

Phrase: "51 m hour1,"

Phrase: "respectively,"

Phrase: "and"

Phrase: "the rates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0871208:Rate [Activity]
   966   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "not significantly different at other intervals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "6 hours after transfection,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C1292428:6 Hours [Temporal Concept]
   770   C0439227:hours [Temporal Concept]
   737 E C0564385:/hour [Quantitative Concept]

Phrase: "demonstrating"

Phrase: "that"

Phrase: "the tyrosine mutants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596988:mutants [Cell or Molecular Dysfunction]

Phrase: "moved at the same rate"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   760   C0445247:Same [Qualitative Concept]
   760   C0871208:Rate [Activity]
   760   C1269909:moved [Functional Concept]
   760   C1299988:moved [Functional Concept]
   760   C1521828:Rate [Quantitative Concept]
   760   C2699029:Moved [Activity]
   726 E C0560560:move [Organism Function]
   726 E C0578671:move [Finding]

Phrase: "as wild-type -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 5B,"

Phrase: "P>0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.154: These results suggest that the phosphorylation state of tyrosine 125 in -synuclein is not involved in the regulation of its axonal transport. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the phosphorylation state of tyrosine 125 in -synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1519726:Tyrosine Phosphorylation [Molecular Function]
   744   C0031715:Phosphorylation [Molecular Function]
   744   C1158886:Phosphorylation [Molecular Function]
   744   C1301808:State [Geographic Area]
   744   C1442792:State [Functional Concept]
   744   C3148680:State [Geographic Area]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "involved in the regulation of its axonal transport."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   793   C1523074:regulation of transport [Cell Function]
   770   C0004462:Axonal Transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1314939:Involved [Functional Concept]
   744   C1317949:Transport [Manufactured Object]
   744   C1327622:Regulation [Biologic Function]
   744   C3495449:transport [Medical Device]
Processing 00000000.tx.155: View larger version (34K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.157: Replacement of tyrosine 125 in -synuclein by aspartate or phenylalanine does not affect -synuclein transport rate in rat cortical neurons. 

Phrase: "Replacement of tyrosine 125 in -synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0035139:Replacement [Therapeutic or Preventive Procedure]
   753   C0559956:Replacement [Functional Concept]
   753   C1555302:Replacement [Idea or Concept]

Phrase: "by aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "phenylalanine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "synuclein transport rate in rat cortical neurons."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   757   C0178766:neuron transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0871208:Rate [Activity]
   748   C1317949:Transport [Manufactured Object]
   748   C1521828:Rate [Quantitative Concept]
   748   C3495449:transport [Medical Device]
Processing 00000000.tx.158: Rat cortical cultures transfected with plasmids expressing EGFP-tagged human wild-type or the Y125D or Y125F mutants of -synuclein, and their distributions were compared by direct fluorescence 4.5 hours after transfection. 

Phrase: "Rat cortical cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0010453:Cultures [Idea or Concept]
   793 E C0220814:culture [Functional Concept]
   793 E C0430400:Culture [Laboratory Procedure]
   793 E C2242979:Culture [Laboratory Procedure]

Phrase: "transfected with plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "expressing"

Phrase: "EGFP-tagged human"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C1171362:expression protein [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "or"

Phrase: "the Y125D"

Phrase: "or"

Phrase: "Y125F mutants of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "their distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0037775:Distributions [Spatial Concept]
   966 E C0520511:distribution [Idea or Concept]
   966 E C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "compared by direct fluorescence 4.5 hours"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0439227:hours [Temporal Concept]
   748   C0439851:Direct [Qualitative Concept]
   748   C1707455:Compared [Activity]
   748   C1947931:Direct [Qualitative Concept]
   714 E C0564385:/hour [Quantitative Concept]

Phrase: "after transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.159: Scale bars, 50 m. 

Phrase: "Scale bars,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: "50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.160: Human wild-type (black), Y125D (white) and Y125F (grey) -synuclein plasmids were transfected into 5 DIV rat cortical cultures. 

Phrase: "Human"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086418:Human [Human]

Phrase: "wild-type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Y125D"

Phrase: "(white"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Y125F"

Phrase: "(grey"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: ") -"

Phrase: "synuclein plasmids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "transfected into 5 DIV rat cortical cultures."
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0001613:Cortical [Body Part, Organ, or Organ Component]
   742   C0007776:Cortical [Body Part, Organ, or Organ Component]
   742   C0010453:Cultures [Idea or Concept]
   742   C0022655:Cortical [Body Part, Organ, or Organ Component]
   742   C0034693:Rat, NOS [Mammal]
   742   C0034721:Rat [Mammal]
   742   C0439228:days [Temporal Concept]
   708 E C0220814:culture [Functional Concept]
   708 E C0332173:/day [Temporal Concept]
   708 E C0430400:Culture [Laboratory Procedure]
   708 E C0439505:/day [Temporal Concept]
   708 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.161: Bars indicate the mean rates of transport  s.e.m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "indicate"

Phrase: "the mean rates of transport"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0444504:Mean [Quantitative Concept]
   760   C2347634:Mean [Quantitative Concept]
   760   C2348143:Mean [Quantitative Concept]
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "s."

Phrase: "e.m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.162: (m hour1) for each construct between 3 hours and 4.5 hours after glycerol shock (n=52-121 neurons).   

Phrase: "(m hour1"

Phrase: ")"

Phrase: "for each construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2827421:Construct [Classification]

Phrase: "between 3 hours"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1442460:3 Hours [Temporal Concept]
   861   C0439227:hours [Temporal Concept]
   827 E C0564385:/hour [Quantitative Concept]

Phrase: "and"

Phrase: "4.5 hours after glycerol shock"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C1292426:4 Hours [Temporal Concept]
   753   C0439227:hours [Temporal Concept]
   719 E C0564385:/hour [Quantitative Concept]

Phrase: "(n=52-121 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.163: Discussion Top Summary Introduction Materials and Methods Results Discussion References  In this study, we have used transfected rat cortical neurons as a model to investigate -synuclein transport following a method developed previously in this laboratory to study axonal transport of neurofilaments and tau protein (Ackerley et al., 2000; Utton et al., 2002; Brownlees et al., 2002; Ackerley et al., 2003). 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References  In this study,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C2985663:Study Reference [Intellectual Product]
   770   C0557651:Study [Manufactured Object]
   770   C1514811:Reference [Idea or Concept]
   770   C1706462:Reference [Conceptual Entity]
   770   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "transfected"

Phrase: "rat cortical neurons as a model to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0027882:Neurons [Cell]

Phrase: "investigate -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "synuclein transport"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "a method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "developed"

Phrase: "previously in this laboratory to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "axonal transport of neurofilaments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "tau protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0085401:tau Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "(Ackerley et al.,"

Phrase: "2000"

Phrase: "; Utton et al.,"

Phrase: "2002"

Phrase: "; Brownlees et al.,"

Phrase: "2002"

Phrase: "; Ackerley et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.164: One condition of using such a method, however, is that the results obtained from cultured cells should correspond to those obtained from in vivo studies. 

Phrase: "One condition of"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0012634:condition [Disease or Syndrome]
   790   C0348080:Condition [Qualitative Concept]
   790   C1705253:Condition [Conceptual Entity]
   718 E C0009647:Conditioned [Mental Process]
   718 E C1701901:Conditional [Qualitative Concept]
   718 E C1963686:Conditional [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "such a method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "however,"

Phrase: "is"

Phrase: "that"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "obtained from cultured cells"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   833   C0007600:cultured cells [Cell]
   833   C0007635:Cultured Cells [Cell]
   833   C3282338:Cells, Cultured [Cell]
   802 E C0007585:cells culture [Laboratory Procedure]
   770   C0007634:Cells [Cell]
   770   C1301820:Obtained [Functional Concept]
   770   C3282337:Cells [Cell]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1706701:Obtain [Activity]
   737 E C1948049:Cell [Spatial Concept]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "should"

Phrase: "correspond to those"

Phrase: "obtained from in vivo studies."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   845   C0681829:in vivo study [Research Activity]
           studies vivo
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0947630:studies [Laboratory Procedure]
   760   C1301820:Obtained [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C1706701:Obtain [Activity]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.165: Axonal transport of -synuclein has been studied previously in the rat optic nerve and most -synuclein has been shown to travel in the slow component of axonal transport at 1.9-2.4 mm day1 (Jensen et al., 1999). 

Phrase: "Axonal transport of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "studied"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]

Phrase: "previously in the rat optic nerve"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1882801:Rat Optic Nerve [Body Part, Organ, or Organ Component]
   790   C0029130:Optic Nerve [Body Part, Organ, or Organ Component]
   790   C1268985:Optic nerve [Body Part, Organ, or Organ Component]
   753   C0015392:Optic [Body Part, Organ, or Organ Component]
   753   C0027740:Nerve [Tissue]
   753   C0027757:NERVE [Tissue]
   753   C0029144:optic [Occupation or Discipline]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "most -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "travel in the slow component"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0040802:travel [Daily or Recreational Activity]
   760   C0439834:Slow [Qualitative Concept]
   760   C0449432:Component [Manufactured Object]
   760   C1555670:travel [Idea or Concept]
   760   C1705248:Component [Conceptual Entity]

Phrase: "of axonal transport at 1.9-2.4 mm day1"

Phrase: "(Jensen et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.166: Here, we have used a simple cellular system and found that the bulk of -synuclein is transported along axons of transfected neurons at an average rate equivalent to 1.3 mm day1. 

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a simple cellular system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the bulk of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "transported along axons of transfected neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004461:Axons [Cell Component]
   753   C0027882:Neurons [Cell]
   750   C0178766:neuron transport [Cell Function]
   725   C0004462:Axonal Transport [Cell Function]
   719   C0005528:Transport, NOS [Cell Function]
   719   C1317949:Transport [Manufactured Object]
   719   C3495449:transport [Medical Device]

Phrase: "at an average rate equivalent"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205163:Equivalent [Qualitative Concept]
   827   C0439185:equivalent [Quantitative Concept]

Phrase: "to 1.3 mm day1."
Processing 00000000.tx.167: Our results in transfected cells are thus broadly similar to those observed in vivo in the optic nerve. 

Phrase: "Our results in transfected cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "are"

Phrase: "thus broadly similar to those observed in vivo"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2348205:Similar [Qualitative Concept]

Phrase: "in the optic nerve."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0029130:Optic Nerve [Body Part, Organ, or Organ Component]
  1000   C1268985:Optic nerve [Body Part, Organ, or Organ Component]
   861   C0015392:Optic [Body Part, Organ, or Organ Component]
   861   C0027740:Nerve [Tissue]
   861   C0027757:NERVE [Tissue]
   861   C0029144:optic [Occupation or Discipline]
   861   C1280541:Nerve [Body Part, Organ, or Organ Component]
   805 E C0599851:Neural [Functional Concept]
   789 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.168: For cytoskeletal protein transport, a slow overall rate of movement is now known to be due to intermittent conventional fast transport (Wang et al., 2000; Wang et al., 2002) and this might well be the case for -synuclein. 

Phrase: "For cytoskeletal protein transport,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0599895:protein transport [Cell Function]
   901   C1159772:Protein Transport [Cell Function]
   827   C0005528:Transport, NOS [Cell Function]
   827   C1317949:Transport [Manufactured Object]
   827   C3495449:transport [Medical Device]
   734   C0010852:Cytoskeletal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1414120:cytoskeletal protein [Gene or Genome]

Phrase: "a slow overall rate of movement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "is"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be due to intermittent conventional fast transport"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   778   C0678226:Due to [Functional Concept]
           due
   774   C1550030:Transport To [Idea or Concept]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0015663:Fast [Finding]
   748   C0205267:Intermittent [Temporal Concept]
   748   C0439858:Conventional [Qualitative Concept]
   748   C0456962:Fast [Qualitative Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   748   C3495449:transport [Medical Device]

Phrase: "(Wang et al.,"

Phrase: "2000"

Phrase: "; Wang et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "be"

Phrase: "the case for -synuclein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]
Processing 00000000.tx.169: These results therefore indicate that our system is a good cellular model, comparable to in vivo models, for determining the parameters of -synuclein axonal transport. 

Phrase: "These results therefore"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "our system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]

Phrase: "is"

Phrase: "a good cellular model,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "comparable to in vivo models,"

Phrase: "for determining"

Phrase: "the parameters of -synuclein axonal transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0004462:Axonal Transport [Cell Function]
   804   C0005528:Transport, NOS [Cell Function]
   804   C1317949:Transport [Manufactured Object]
   804   C3495449:transport [Medical Device]
   733   C0004461:Axon [Cell Component]
Processing 00000000.tx.170: Axonal transport of both A30P and A53T, -synuclein mutations associated with rare forms of familial Parkinson's disease, was significantly attenuated compared with the wild-type protein. 

Phrase: "Axonal transport of both A30P"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0004462:Axonal Transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "A53T, -"

Phrase: "synuclein mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "associated with rare forms of familial Parkinson's disease,"
Meta Candidates (Total=21; Excluded=4; Pruned=0; Remaining=17)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   767   C0243083:associated disease [Pathologic Function]
   767   C0277558:Familial disease [Disease or Syndrome]
   767   C0678236:Rare Disease [Disease or Syndrome]
   750   C1832428:Familial form [Finding]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:familial [Family Group]
   744   C0241888:Familial [Functional Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0521114:Rare [Temporal Concept]
   744   C0522498:Rare [Qualitative Concept]
   744   C1514917:RARE [Gene or Genome]
   731 E C0344339:disease family [Finding]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "compared with the wild-type protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1883559:Wild Type [Organism Attribute]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]
   753   C1707455:Compared [Activity]
Processing 00000000.tx.171: Hence, reduced axonal transport of mutant forms of -synuclein might explain, at least in part, the finding of A30P and A53T -synuclein accumulation in transgenic mice (Sommer et al., 2000; Kahle et al., 2000; Van der Putten et al., 2000; Lee et al., 2002; Lo et al., 2002). 

Phrase: "Hence,"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "axonal transport of mutant forms of -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0004462:Axonal Transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C1317949:Transport [Manufactured Object]
   748   C3495449:transport [Medical Device]

Phrase: "might"

Phrase: "explain"

Phrase: ","

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "in part,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "the finding of A30P"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037088:Finding [Sign or Symptom]
   770   C0243095:Finding [Finding]
   770   C2825141:Finding [Finding]

Phrase: "and"

Phrase: "A53T -synuclein accumulation in transgenic mice"

Phrase: "(Sommer et al.,"

Phrase: "2000"

Phrase: "; Kahle et al.,"

Phrase: "2000"

Phrase: "; Van der Putten et al.,"

Phrase: "2000"

Phrase: "; Lee et al.,"

Phrase: "2002"

Phrase: "; Lo et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.172: The rates of transport of wild-type compared with A30P and A53T mutant -synuclein differed most at the earlier time points in this study, possibly representing an increased lag phase in transport of the mutant proteins. 

Phrase: "The rates of transport of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0871208:Rate [Activity]
   714   C1521828:Rate [Quantitative Concept]

Phrase: "compared with A30P"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "A53T mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "differed"

Phrase: "most at the earlier time points"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C2348792:Time Point [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0205393:Most [Quantitative Concept]
   753   C3541383:Time [Temporal Concept]
   719   C1279919:Early [Temporal Concept]
   719   C1552961:Point [Quantitative Concept]
   719   C2347617:point [Quantitative Concept]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "an increased lag phase in transport of the mutant proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0205390:Phase [Temporal Concept]
   739   C1416797:Lag [Gene or Genome]
Processing 00000000.tx.173: This suggests to us that the rate of association of A30P and A53T -synuclein with other proteins involved in access to the neuronal transport machinery might be affected by the presence of the A30P and A53T mutations in -synuclein. 

Phrase: "This"

Phrase: "suggests to us"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the rate of association of A30P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0871208:Rate [Activity]
   753   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "A53T -synuclein with other proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in access"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0444454:Access [Spatial Concept]
   790   C1314939:Involved [Functional Concept]
   790   C1554204:access [Idea or Concept]

Phrase: "to the neuronal transport machinery"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0337076:machinery [Manufactured Object]
   734   C0178766:neuronal transport [Cell Function]

Phrase: "might"

Phrase: "be"

Phrase: "affected by the presence of the A30P"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392760:Affected [Functional Concept]
   748   C1314939:Affected [Functional Concept]
   714 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "A53T mutations in -synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.174: One possibility is that the rate of association/disassociation of -synuclein with the motor and/or accessory proteins involved in its initial transport from the cell body might be a crucial rate-determining step in -synuclein axonal transport, and this might be disrupted by the two causal Parkinson's disease mutations. 

Phrase: "One possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0332149:Possible [Qualitative Concept]
   789   C1705910:Possible [Qualitative Concept]
   789   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the rate of association/disassociation of -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "with the motor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513492:Motor [Functional Concept]
  1000   C1705994:Motor [Manufactured Object]

Phrase: "and/or"

Phrase: "accessory proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in its initial transport"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0005528:Transport, NOS [Cell Function]
   760   C0205265:Initial [Temporal Concept]
   760   C1279901:Initial [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1317949:Transport [Manufactured Object]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]
   760   C3495449:transport [Medical Device]

Phrase: "from the cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "might"

Phrase: "be"

Phrase: "a crucial rate-determining step in -synuclein axonal transport,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0004462:Axonal Transport [Cell Function]
   793   C0005528:Transport, NOS [Cell Function]
   793   C1317949:Transport [Manufactured Object]
   793   C3495449:transport [Medical Device]
   721   C0004461:Axon [Cell Component]

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "be"

Phrase: "disrupted by the two causal Parkinson's disease mutations."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0026882:Mutations [Genetic Function]
   744   C0205448:Two [Quantitative Concept]
   744   C0332454:Disrupted [Qualitative Concept]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.175: At later times following transfection, the transport rate of mutant -synuclein was less affected than at earlier times, when the newly synthesized mutant protein was starting to leave the cell body and travel along the proximal axon. 

Phrase: "At later times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the transport rate of mutant -synuclein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005528:Transport, NOS [Cell Function]
   753   C0871208:Rate [Activity]
   753   C1317949:Transport [Manufactured Object]
   753   C1521828:Rate [Quantitative Concept]
   753   C3495449:transport [Medical Device]

Phrase: "was"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "affected than"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0392760:Affected [Functional Concept]
   833   C1314939:Affected [Functional Concept]
   799 E C0001721:Affect [Mental Process]

Phrase: "at earlier times,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "when"

Phrase: "the newly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750546:newly [Idea or Concept]

Phrase: "synthesized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883254:Synthesized [Activity]

Phrase: "mutant protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1564139:Mutant Protein [Amino Acid, Peptide, or Protein]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "starting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Start [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "leave"

Phrase: "the cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "and"

Phrase: "travel along the proximal axon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040802:travel [Daily or Recreational Activity]
   760   C1555670:travel [Idea or Concept]
Processing 00000000.tx.176: This result is therefore in line with our hypothesis that the rate of -synuclein egress from the cell body might be impeded by the presence of mutations. 

Phrase: "This result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "therefore in line with our hypothesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205132:Line [Spatial Concept]
   753   C1512571:Hypothesis [Idea or Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "that"

Phrase: "the rate of -synuclein egress from the cell body"

Phrase: "might"

Phrase: "be"

Phrase: "impeded by the presence of mutations."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0026882:Mutations [Genetic Function]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.177: A possible mechanism for the reduced rates of transport of A30P -synuclein at early time-points might be related to inhibition of its interaction with lipid membranes and vesicles, which might slow the rate at which -synuclein can associate with components involved in neuronal transport (Jensen et al., 1998; Perrin et al., 2000; Jo et al., 2002). 

Phrase: "A possible mechanism for the reduced rates of transport of A30P -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   736   C0441712:Mechanism [Functional Concept]
   736   C1706376:Mechanism [Manufactured Object]

Phrase: "at early time-points"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   867   C2348792:Time Point [Temporal Concept]
   827   C0040223:Time [Temporal Concept]
   827   C3541383:Time [Temporal Concept]
   793   C1552961:Point [Quantitative Concept]
   793   C2347617:point [Quantitative Concept]
   771 E C0442043:Temporal [Spatial Concept]
   771 E C2362314:Temporal [Temporal Concept]
   743 E C1632851:Times [Quantitative Concept]

Phrase: "might"

Phrase: "be"

Phrase: "related to inhibition of its interaction"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C0439849:Related [Qualitative Concept]
   753   C0445223:Related [Finding]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C1704675:Interaction [Functional Concept]
   753   C3463820:Inhibition [Activity]
   719 E C0163712:Relate [Organic Chemical]

Phrase: "with lipid membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0333262:VESICLES [Acquired Abnormality]
   966 E C1622418:vesicle [Cell Component]
   916 E C0205378:Vesicular [Qualitative Concept]

Phrase: "which"

Phrase: "might"

Phrase: "slow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "the rate at which -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "can"

Phrase: "associate with components"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449432:Components [Manufactured Object]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]
   756 E C1705248:Component [Conceptual Entity]

Phrase: "involved in neuronal transport"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0178766:neuronal transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1314939:Involved [Functional Concept]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "(Jensen et al.,"

Phrase: "1998"

Phrase: "; Perrin et al.,"

Phrase: "2000"

Phrase: "; Jo et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.178: It is possible that the rate of association and/or disassociation of -synuclein with the proteins involved in its initial export from the cell body is a crucial rate-determining step in its axonal transport. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the rate of association"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "and/or"

Phrase: "disassociation of -synuclein with the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in its initial export"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205265:Initial [Temporal Concept]
   760   C0699789:Export [Phenomenon or Process]
   760   C1279901:Initial [Qualitative Concept]
   760   C1314939:Involved [Functional Concept]
   760   C1555582:Initial [Idea or Concept]
   760   C1705685:INITIAL [Functional Concept]

Phrase: "from the cell body"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0599444:Cell body [Cell Component]
  1000   C2752549:cell body [Cell Component]
   861   C0007634:Cell [Cell]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "is"

Phrase: "a crucial rate-determining step in its axonal transport."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0871208:Rate [Activity]
   742   C1261552:Step [Conceptual Entity]
   742   C1521828:Rate [Quantitative Concept]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]
Processing 00000000.tx.179: Thus, it is feasible that a transport control mechanism might exist in which proteins are gated through a region of the axon close to the cell body, although further studies are required to confirm this hypothesis. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "is"

Phrase: "feasible"

Phrase: "that"

Phrase: "a transport control mechanism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0243148:control [Qualitative Concept]
   827   C0441712:Mechanism [Functional Concept]
   827   C1550141:Control [Substance]
   827   C1706376:Mechanism [Manufactured Object]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "might"

Phrase: "exist in which proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2987476:Exist [Conceptual Entity]

Phrase: "are"

Phrase: "gated through a region of the axon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0004461:Axon [Cell Component]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "close to the cell body,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C0599444:Cell body [Cell Component]
   806   C2752549:cell body [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C0587267:Close [Functional Concept]
   760   C1268086:Body [Anatomical Structure]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "although"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.180: Phosphorylation of -synuclein is known to occur on serine residues 87 and 129 as well as tyrosine residues (Okochi et al., 2000; Pronin et al., 2000; Nakamura et al., 2001; Ellis et al., 2001; Negro et al., 2002; Nakamura et al., 2002). 

Phrase: "Phosphorylation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur on serine residues 87"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726   C1709915:Residue [Conceptual Entity]
   726   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "and"

Phrase: "129"

Phrase: "as well as"

Phrase: "tyrosine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(Okochi et al.,"

Phrase: "2000"

Phrase: "; Pronin et al.,"

Phrase: "2000"

Phrase: "; Nakamura et al.,"

Phrase: "2001"

Phrase: "; Ellis et al.,"

Phrase: "2001"

Phrase: "; Negro et al.,"

Phrase: "2002"

Phrase: "; Nakamura et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.181: Here, we have demonstrated that mimicking protein phosphorylation by mutating specific serine residues to aspartate might have a direct influence on -synuclein axonal transport as each of the S87D and S129D mutations reduced the rate of -synuclein transport. 

Phrase: "Here,"

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that mimicking protein phosphorylation by mutating specific serine residues"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]

Phrase: "to aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "might"

Phrase: "have"

Phrase: "a direct influence on -synuclein axonal transport as each of the S87D"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004462:Axonal Transport [Cell Function]
   736   C0005528:Transport, NOS [Cell Function]
   736   C1317949:Transport [Manufactured Object]
   736   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "S129D mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the rate of -synuclein transport."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005528:Transport, NOS [Cell Function]
   812   C1317949:Transport [Manufactured Object]
   812   C3495449:transport [Medical Device]
Processing 00000000.tx.182: Serine 87 is unique to human -synuclein and lies within the non-A component of Alzheimer's disease amyloid portion of -synuclein, close to a region of -synuclein that is pivotal in its ability to aggregate in vitro (Giasson et al., 2001). 

Phrase: "Serine 87"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "is"

Phrase: "unique to human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710548:Unique [Qualitative Concept]

Phrase: "and"

Phrase: "lies within the non-A component"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0449432:Component [Manufactured Object]
   753   C1518422:Non [Functional Concept]
   753   C1705248:Component [Conceptual Entity]

Phrase: "of Alzheimer's disease amyloid portion of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "close to a region of -synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017446:Region [Geographic Area]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0205147:Region [Spatial Concept]
   753   C0587267:Close [Functional Concept]

Phrase: "that"

Phrase: "is"

Phrase: "pivotal in its ability to"

Phrase: "aggregate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205418:Aggregate [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Giasson et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.183: Phosphorylation of serine 87 might therefore have a significant influence on the conformation of -synuclein and this could affect the interaction of -synuclein with proteins involved in its transport. 

Phrase: "Phosphorylation of serine 87"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0031715:Phosphorylation [Molecular Function]
   770   C1158886:Phosphorylation [Molecular Function]

Phrase: "might"

Phrase: "therefore"

Phrase: "have"

Phrase: "a significant influence on the conformation of -synuclein"

Phrase: "and"

Phrase: "this"

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the interaction of -synuclein with proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "involved in its transport."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0005528:Transport, NOS [Cell Function]
   770   C1314939:Involved [Functional Concept]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]
Processing 00000000.tx.184: It has been reported recently that phosphorylation of serine 129 in -synuclein promotes the formation of -synuclein filaments in vitro (Fujiwara et al., 2002). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "that phosphorylation of serine 129 in -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031715:Phosphorylation [Molecular Function]
   748   C1158886:Phosphorylation [Molecular Function]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the formation of -synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Fujiwara et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.185: -Synuclein-containing lesions in human brain and in transgenic mice overexpressing human -synuclein are highly phosphorylated at serine 129, suggesting that increased phosphorylation at this site might cause it to accumulate in diseased neurons (Fujiwara et al., 2002; Kahle et al., 2002). 

Phrase: "-Synuclein-containing lesions in human brain"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0221505:brain lesions [Disease or Syndrome]
   753   C0221198:lesions [Finding]
   719 E C1546698:Lesion [Intellectual Product]

Phrase: "and in transgenic mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0025936:Mice, Transgenic [Mammal]
   770   C0003069:Transgenic [Animal]
   770   C0025914:Mice [Mammal]
   770   C0025929:mice [Mammal]
   770   C0026809:Mice [Mammal]
   770   C1515981:And [Idea or Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "highly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205250:Highly [Qualitative Concept]

Phrase: "phosphorylated at serine 129,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that increased phosphorylation at this site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1519063:Phosphorylation Site [Amino Acid Sequence]
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "might"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "it to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "accumulate in diseased neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "(Fujiwara et al.,"

Phrase: "2002"

Phrase: "; Kahle et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.186: We therefore propose that at least some -synuclein accumulations might result from mechanisms causing reduced transport of the phosphorylated form of the protein. 

Phrase: "We therefore"

Phrase: "propose"

Phrase: "that at least"

Phrase: "some -synuclein accumulations"

Phrase: "might"

Phrase: "result from mechanisms"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0441712:Mechanisms [Functional Concept]
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]
   756 E C1706376:Mechanism [Manufactured Object]

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "reduced transport of the phosphorylated form of the protein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C0599895:protein transport [Cell Function]
   762   C1159772:Protein Transport [Cell Function]
   742   C0005528:Transport, NOS [Cell Function]
   742   C1317949:Transport [Manufactured Object]
   742   C3495449:transport [Medical Device]
Processing 00000000.tx.187: We found no effect of -synuclein on axonal transport when tyrosine 125 was replaced by either aspartate or phenylalanine, suggesting that a mutation in -synuclein at its C-terminus does not cause a generalized non-specific inhibitory effect on its transport in neurons. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "no effect of -synuclein on axonal transport"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "when"

Phrase: "tyrosine 125"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "was"

Phrase: "replaced by either aspartate"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C1299987:Replaced by [Functional Concept]
           replaced
   770   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0559956:Replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "or"

Phrase: "phenylalanine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031453:Phenylalanine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a mutation in -synuclein at its C-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a generalized non-specific inhibitory effect on its transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: "in neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.188: The Y125D tyrosine mutant used in this study is likely to have caused significant alterations in the structure adopted by -synuclein in this region of the molecule and this might therefore have been expected to affect -synuclein transport owing to conformational changes. 

Phrase: "The Y125D tyrosine mutant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596988:Mutant [Cell or Molecular Dysfunction]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "have"

Phrase: "caused significant alterations in the structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1515926:Alteration [Idea or Concept]

Phrase: "adopted by -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0425382:Adopted [Finding]

Phrase: "in this region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0017446:Region [Geographic Area]
  1000   C0205147:Region [Spatial Concept]
   928 E C0205276:Regional [Spatial Concept]
   928 E C1947913:Regional [Spatial Concept]

Phrase: "of the molecule"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:Molecule [Substance]
   928 E C1521991:Molecular [Qualitative Concept]

Phrase: "and"

Phrase: "this"

Phrase: "might"

Phrase: "therefore"

Phrase: "have"

Phrase: "been"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "affect -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "synuclein transport owing to conformational changes."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1550030:Transport To [Idea or Concept]
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]
Processing 00000000.tx.189: In keeping with this assumption, the presence of the negatively charged aspartate residue in place of tyrosine did result in a slightly retarded electrophoretic mobility of Y125D -synuclein on polyacrylamide gels, suggesting that the Y125D mutant -synuclein does exhibit a different conformation to the wild-type protein (J.H. and D.P.H., unpublished). 

Phrase: "In keeping"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0333118:Keep [Functional Concept]

Phrase: "with this assumption,"

Phrase: "the presence of the negatively charged aspartate residue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in place of tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "did"

Phrase: "result in a slightly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0750482:Slightly [Idea or Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "retarded"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0521111:Retarded [Qualitative Concept]
   928 E C0311403:Inhibited [Qualitative Concept]
   928 E C3463820:Inhibiting [Activity]
   907 E C0018790:arrested [Disease or Syndrome]
   907 E C0237477:Arrest [Temporal Concept]
   907 E C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "electrophoretic mobility of Y125D -synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "on polyacrylamide gels,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   861   C0017243:Gels [Biomedical or Dental Material]
   861   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   827 E C1382104:Gel [Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the Y125D mutant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "does"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a different conformation to the wild-type protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0033625:Protein Conformation [Spatial Concept]
   744   C0026377:Conformation [Spatial Concept]

Phrase: "(J.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "D.P.H.,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C1512024:D.P. [Intellectual Product]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "unpublished"

Phrase: ")."
Processing 00000000.tx.190: Successful mimics of permanent tyrosine phosphorylation have been reported using substitution of tyrosine for aspartate residues in proteins (Wu et al., 1998; Bonvini et al., 2001), although we cannot exclude the possibility that, in the case of -synuclein, replacing tyrosine (a large hydrophobic amino acid) with aspartate is not an accurate mimic of phosphorylation in our model system. 

Phrase: "Successful"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1272703:Successful [Qualitative Concept]
   928 E C0597535:Success [Social Behavior]

Phrase: "mimics of permanent tyrosine phosphorylation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C1519726:Tyrosine Phosphorylation [Molecular Function]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0205355:Permanent [Temporal Concept]
   760   C0393040:mimics [Therapeutic or Preventive Procedure]
   760   C1158886:Phosphorylation [Molecular Function]
   760   C1176299:mimics [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "have"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "substitution of tyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1555721:Substitution [Idea or Concept]
   790   C1706204:Substitution [Activity]

Phrase: "for aspartate residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "in proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Wu et al.,"

Phrase: "1998"

Phrase: "; Bonvini et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility"

Phrase: "that,"

Phrase: "in the case of -synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "replacing"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299987:replacing [Functional Concept]
   966 E C1554078:Replace [Idea or Concept]

Phrase: "tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "("

Phrase: "a large hydrophobic amino acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C2917660:Amino Acid [Pharmacologic Substance]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "with aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "an accurate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443131:Accurate [Qualitative Concept]

Phrase: "mimic of phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0031715:Phosphorylation [Molecular Function]
   790   C1158886:Phosphorylation [Molecular Function]

Phrase: "in our model system."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0026339:Model System [Intellectual Product,Research Device]
  1000   C3161035:Model System [Intellectual Product]
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.191: However, because neither Y125D nor Y125F -synuclein affected transport rates in neurons, we conclude that there is no evidence for the involvement of tyrosine 125 in regulation of its axonal transport. 

Phrase: "However,"

Phrase: "because"

Phrase: "neither Y125D"

Phrase: "nor"

Phrase: "Y125F -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "transport rates in neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   802   C0178766:neuron transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "we"

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that there"

Phrase: "is"

Phrase: "no evidence for the involvement of tyrosine 125"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of its axonal transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]
Processing 00000000.tx.192: In conclusion, our results show that both of the Parkinson's disease-associated mutations in -synuclein significantly reduce its rate of transport in neurons and that phosphorylation also appears to have an important role to play in the regulation of -synuclein axonal transport. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "both of the Parkinson's disease-associated mutations in -synuclein significantly"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   760   C0030567:Parkinson Disease [Disease or Syndrome]
   760   C1521736:Parkinson's Disease [Functional Concept]
   760   C2681933:PARKINSON DISEASE [Gene or Genome]
   757   C0243083:associated disease [Pathologic Function]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0026882:Mutations [Genetic Function]
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0238767:Both [Spatial Concept]
   739   C0332281:Associated [Qualitative Concept]
   739   C1706086:Both [Qualitative Concept]
   706 E C0750490:Associate [Idea or Concept]
   706 E C1705285:Mutation [Cell or Molecular Dysfunction]
   706 E C1706221:Associate [Professional or Occupational Group]

Phrase: "reduce"

Phrase: "its rate of transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "that phosphorylation also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "an important role to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035820:Role [Social Behavior]
   827   C1705810:Role [Conceptual Entity]

Phrase: "play in the regulation of -synuclein axonal transport."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   793   C1523074:regulation of transport [Cell Function]
   770   C0004462:Axonal Transport [Cell Function]
   744   C0005528:Transport, NOS [Cell Function]
   744   C0032214:Play [Daily or Recreational Activity]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0600138:play [Finding]
   744   C0851285:Regulation [Governmental or Regulatory Activity]
   744   C1317949:Transport [Manufactured Object]
   744   C1327622:Regulation [Biologic Function]
   744   C3495449:transport [Medical Device]
Processing 00000000.tx.193: Defects in -synuclein or its processing enzymes might be responsible for inhibition of normal transport processes in neurons in neurodegenerative disease and this could lead to the development of Lewy pathology and/or neuronal death. 

Phrase: "Defects in -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "its processing enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]

Phrase: "might"

Phrase: "be"

Phrase: "responsible for inhibition of normal transport processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in neurodegenerative disease"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "this"

Phrase: "could"

Phrase: "lead to the development of Lewy pathology"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C0030664:Pathology [Biomedical Occupation or Discipline]
   748   C0205469:pathology [Functional Concept]
   748   C0243107:development [Physiologic Function]
   748   C0677042:pathology [Pathologic Function]
   748   C0678723:Development [Organism Function]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C1527148:Development [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and/or"

Phrase: "neuronal death."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C2754100:neuron death [Cell Function]
   861   C0011065:Death [Organism Function]
   861   C1306577:Death, NOS [Finding]
Processing 00000000.tx.194: Using the model cellular system described here, we can now begin to examine the mechanisms involved in -synuclein transport in neurons, including identifying the motor proteins. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the model cellular system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   913   C0026339:Model System [Intellectual Product,Research Device]
   913   C3161035:Model System [Intellectual Product]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here,"

Phrase: "we"

Phrase: "can"

Phrase: "now"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948052:Now [Temporal Concept]

Phrase: "begin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Begin [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "in -synuclein transport in neurons,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0178766:neuron transport [Cell Function]
   760   C0005528:Transport, NOS [Cell Function]
   760   C1317949:Transport [Manufactured Object]
   760   C3495449:transport [Medical Device]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "identifying"

Phrase: "the motor proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C1179106:Motor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.195: This is a key step in expanding our understanding of potential mechanisms involved in the pathogenesis of neurodegenerative disease.  

Phrase: "This"

Phrase: "is"

Phrase: "a key step in expanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0205229:Expanding [Spatial Concept]

Phrase: "our understanding of potential mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "involved in the pathogenesis of neurodegenerative disease."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0543483:pathogenesis [Functional Concept]
   748   C0699748:Pathogenesis [Pathologic Function]
   748   C1314939:Involved [Functional Concept]
Processing 00000000.tx.196: Acknowledgments  This work was supported by The Wellcome Trust, the Alzheimer's Society, the Parkinson's Disease Society and the Medical Research Council. 

Phrase: "Acknowledgments"

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by The Wellcome Trust,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0237935:Trust [Individual Behavior]
   760   C1521721:Supported [Conceptual Entity]
   760   C3245466:trust [Idea or Concept]
   726 E C0183683:Support [Medical Device]

Phrase: "the Alzheimer's Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "the Parkinson's Disease Society"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0037455:society [Organization]
   734   C0030567:Parkinson Disease [Disease or Syndrome]
   734   C1521736:Parkinson's Disease [Functional Concept]
   734   C2681933:PARKINSON DISEASE [Gene or Genome]

Phrase: "and"

Phrase: "the Medical Research Council."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0079816:Medical Research [Research Activity]
   901   C1556038:Medical Research [Professional or Occupational Group]
   827   C0035168:research [Research Activity]
   827   C0205476:Medical [Functional Concept]
   827   C0242481:Research [Research Activity]
   827   C1551807:Council [Population Group]
Processing 00000000.tx.197: We thank J.-M. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "J.-M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.198: Gallo for many helpful discussions.  

Phrase: "Gallo for many helpful discussions."
Processing 00000000.tx.199: Footnotes  * These authors contributed equally to this work  References Top Summary Introduction Materials and Methods Results Discussion References  Ackerley, S., Grierson, A. 

Phrase: "Footnotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "These authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0221193:Authors [Professional or Occupational Group]

Phrase: "contributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1880177:Contribute [Activity]

Phrase: "equally to this work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0043227:Work [Occupational Activity]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Ackerley,"

Phrase: "S."

Phrase: ","

Phrase: "Grierson,"

Phrase: "A."
Processing 00000000.tx.200: J., Brownlees, J., Thornhill, P., Anderton, B. 

Phrase: "J.,"

Phrase: "Brownlees,"

Phrase: "J.,"

Phrase: "Thornhill,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.201: H., Leigh, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leigh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.202: N., Shaw, C. 

Phrase: "N., Shaw,"

Phrase: "C."
Processing 00000000.tx.203: E. and Miller, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.204: C. 

Phrase: "C."
Processing 00000000.tx.205: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.206: Glutamate slows axonal transport of neurofilaments in transfected neurons. 

Phrase: "Glutamate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017789:glutamate [Amino Acid, Peptide, or Protein]
  1000   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "slows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439834:Slow [Qualitative Concept]

Phrase: "axonal transport of neurofilaments"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "in transfected neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.207: J. 

Phrase: "J."
Processing 00000000.tx.208: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.209: 150, 165-176.[Abstract/Free FullText] Ackerley, S., Thornhill, P., Grierson, A. 

Phrase: "150,"

Phrase: "165-176."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ackerley,"

Phrase: "S."

Phrase: ","

Phrase: "Thornhill,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Grierson,"

Phrase: "A."
Processing 00000000.tx.210: J., Brownlees, J., Anderton, B. 

Phrase: "J.,"

Phrase: "Brownlees,"

Phrase: "J.,"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.211: H., Leigh, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leigh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.212: N., Shaw, C. 

Phrase: "N., Shaw,"

Phrase: "C."
Processing 00000000.tx.213: E. and Miller, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.214: C. 

Phrase: "C."
Processing 00000000.tx.215: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.216: Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. 

Phrase: "Neurofilament heavy chain side arm phosphorylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0031715:Phosphorylation [Molecular Function]
   799   C1158886:Phosphorylation [Molecular Function]

Phrase: "regulates"

Phrase: "axonal transport of neurofilaments."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]
Processing 00000000.tx.217: J. 

Phrase: "J."
Processing 00000000.tx.218: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.219: 161, 489-495.[Abstract/Free FullText] Antonsson, B., Kassel, D. 

Phrase: "161,"

Phrase: "489-495."

Phrase: "[Abstract/Free FullText"

Phrase: "] Antonsson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kassel,"

Phrase: "D."
Processing 00000000.tx.220: B., di Paolo, G., Lutjens, R., Riederer, B. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "di Paolo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C3538902:DI [Gene or Genome]
   861   C3541881:DI [Idea or Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lutjens,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Riederer,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.221: M. and Grenningloh, G. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Grenningloh,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.222: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.223: Identification of in vitro phosphorylation sites in the growth cone protein SCG10. 

Phrase: "Identification of in vitro phosphorylation sites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0020792:Identification [Mental Process]
   753   C0205396:Identification [Qualitative Concept]

Phrase: "in the growth cone protein SCG10."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1419850:SCG10 [Gene or Genome]
Processing 00000000.tx.224: Effect of phosphorylation site mutants on microtubule-destabilizing activity. 

Phrase: "Effect of phosphorylation site mutants"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on microtubule-destabilizing activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.225: J. 

Phrase: "J."
Processing 00000000.tx.226: Biol. 

Phrase: "Biol."
Processing 00000000.tx.227: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.228: 273, 8439-8446.[Abstract/Free FullText] Bonvini, P., An, W. 

Phrase: "273,"

Phrase: "8439-8446."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bonvini,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "An,"

Phrase: "W."
Processing 00000000.tx.229: G., Rosolen, A., Nguyen, P., Trepel, J., Garcia, d. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rosolen,"

Phrase: "A.,"

Phrase: "Nguyen,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Trepel,"

Phrase: "J.,"

Phrase: "Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442999:Garcia [Intellectual Product]
  1000   C1621797:Garcia [Plant]

Phrase: "d."
Processing 00000000.tx.230: H., Dunach, M. and Neckers, L. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Dunach,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Neckers,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.231: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.232: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.233: Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. 

Phrase: "Geldanamycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0061179:geldanamycin [Antibiotic,Organic Chemical]

Phrase: "abrogates"

Phrase: "ErbB2 association with proteasome-resistant beta-catenin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "in melanoma cells,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C1513095:Melanoma Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "beta-catenin-E-cadherin association,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0004083:Association [Mental Process]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "beta-catenin-sensitive transcription."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0040649:Transcription [Genetic Function]
Processing 00000000.tx.234: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.235: 61, 1671-1677.[Abstract/Free FullText] Braak, H., Sandmann-Keil, D., Gai, W. and Braak, E. 

Phrase: "61,"

Phrase: "1671-1677."

Phrase: "[Abstract/Free FullText"

Phrase: "] Braak,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sandmann-Keil,"

Phrase: "D."

Phrase: ","

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W."

Phrase: "and"

Phrase: "Braak,"

Phrase: "E."
Processing 00000000.tx.236: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.237: Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. 

Phrase: "Extensive axonal Lewy neurites in Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0085103:Neurites [Cell Component]
   745   C3548404:Lewy neurite [Cell Component]

Phrase: ":"

Phrase: "a novel pathological feature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "revealed by alpha-synuclein immunocytochemistry."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0242349:Immunocytochemistry [Laboratory Procedure]
   760   C0439095:Alpha [Intellectual Product]
   760   C0443289:Revealed [Qualitative Concept]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.238: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.239: Lett. 

Phrase: "Lett."
Processing 00000000.tx.240: 265, 67-69.[CrossRef][Medline] Brion, J.-P., Couck, A. 

Phrase: "265,"

Phrase: "67-69."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450388:69 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brion,"

Phrase: "J.-P.,"

Phrase: "Couck,"

Phrase: "A."
Processing 00000000.tx.241: M., Robertson, J., Loviny, T. 

Phrase: "M."

Phrase: ","

Phrase: "Robertson,"

Phrase: "J.,"

Phrase: "Loviny,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.242: L. and Anderton, B. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.243: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.244: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.245: Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease. 

Phrase: "Neurofilament monoclonal antibodies RT97"

Phrase: "and"

Phrase: "8D8"

Phrase: "recognize"

Phrase: "different modified epitopes in paired helical filament-tau"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0003316:Epitopes [Immunologic Factor]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.246: J. 

Phrase: "J."
Processing 00000000.tx.247: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.248: 60, 1372-1382.[Medline] Brownlees, J., Ackerley, S., Grierson, A. 

Phrase: "60,"

Phrase: "1372-1382."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brownlees,"

Phrase: "J.,"

Phrase: "Ackerley,"

Phrase: "S."

Phrase: ","

Phrase: "Grierson,"

Phrase: "A."
Processing 00000000.tx.249: J., Jacobsen, N. 

Phrase: "J.,"

Phrase: "Jacobsen,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.250: J., Shea, K. 

Phrase: "J.,"

Phrase: "Shea,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.251: Anderton, B. 

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.252: H., Leigh, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Leigh,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.253: N., Shaw, C. 

Phrase: "N., Shaw,"

Phrase: "C."
Processing 00000000.tx.254: E. and Miller, C. 

Phrase: "E."

Phrase: "and"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.255: C. 

Phrase: "C."
Processing 00000000.tx.256: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.257: Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport. 

Phrase: "Charcot-Marie-Tooth disease neurofilament mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0007959:Charcot-Marie-Tooth Disease [Disease or Syndrome]
           Charcot-Marie Disease

Phrase: "disrupt"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "neurofilament assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "axonal transport."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0004462:Axonal Transport [Cell Function]
   861   C0005528:Transport, NOS [Cell Function]
   861   C1317949:Transport [Manufactured Object]
   861   C3495449:transport [Medical Device]
   789   C0004461:Axon [Cell Component]
Processing 00000000.tx.258: Hum. 

Phrase: "Hum."
Processing 00000000.tx.259: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.260: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.261: 11, 2837-2844.[Abstract/Free FullText] Davis, D. 

Phrase: "11,"

Phrase: "2837-2844."

Phrase: "[Abstract/Free FullText"

Phrase: "] Davis,"

Phrase: "D."
Processing 00000000.tx.262: R. et al. 

Phrase: "R. et al."
Processing 00000000.tx.263: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.264: The phosphorylation state of the microtubule-associated protein tau as affected by glutamate, colchicine and -amyloid in primary rat cortical neuronal cultures. 

Phrase: "The phosphorylation state of the microtubule-associated protein tau"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1158886:Protein phosphorylation [Molecular Function]
           Phosphorylation
   742   C0031715:Phosphorylation [Molecular Function]
   742   C1301808:State [Geographic Area]
   742   C1442792:State [Functional Concept]
   742   C3148680:State [Geographic Area]

Phrase: "as"

Phrase: "affected by glutamate,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   790   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0392760:Affected [Functional Concept]
   790   C1314939:Affected [Functional Concept]
   756 E C0001721:Affect [Mental Process]

Phrase: "colchicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009262:Colchicine [Organic Chemical,Pharmacologic Substance]

Phrase: "and -"

Phrase: "amyloid in primary rat cortical neuronal cultures."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0011560:Amyloid [Pathologic Function]
   748   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.265: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.266: J. 

Phrase: "J."
Processing 00000000.tx.267: 309, 941-949.[Medline] Ellis, C. 

Phrase: "309,"

Phrase: "941-949."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ellis,"

Phrase: "C."
Processing 00000000.tx.268: E., Schwartzberg, P. 

Phrase: "E.,"

Phrase: "Schwartzberg,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.269: L., Grider, T. 

Phrase: "L., Grider,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.270: L., Fink, D. 

Phrase: "L., Fink,"

Phrase: "D."
Processing 00000000.tx.271: W. and Nussbaum, R. 

Phrase: "W."

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.272: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.273: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.274: Alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. 

Phrase: "Alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "phosphorylated by members of the Src family of protein-tyrosine kinases."
Meta Candidates (Total=19; Excluded=2; Pruned=0; Remaining=17)
   792   C0282625:Protein-Tyrosine Kinases, src [Amino Acid, Peptide, or Protein,Enzyme]
           src-Family Tyrosine Kinases
           src Tyrosine Kinases
           src-Family Kinases
           src Kinases
   775   C0033681:Protein-Tyrosine Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           kinases tyrosine
   754   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   754   C0086282:Family Members [Family Group]
   754   C1335532:Protein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0015576:Family [Family Group]
   738   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           Kinase Family
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   738   C0680022:members [Population Group]
   738   C1704727:Family [Conceptual Entity]
   737 E C1611821:Family Member [Intellectual Product]
   704 E C2698041:Member [Professional or Occupational Group]
Processing 00000000.tx.275: J. 

Phrase: "J."
Processing 00000000.tx.276: Biol. 

Phrase: "Biol."
Processing 00000000.tx.277: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.278: 276, 3879-3884.[Abstract/Free FullText] Feany, M. 

Phrase: "276,"

Phrase: "3879-3884."

Phrase: "[Abstract/Free FullText"

Phrase: "] Feany,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.279: B. and Bender, W. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Bender,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0491941:BENDER [Medical Device]

Phrase: "W."
Processing 00000000.tx.280: W. 

Phrase: "W."
Processing 00000000.tx.281: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.282: A Drosophila model of Parkinson's disease. 

Phrase: "A Drosophila model of Parkinson's disease."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0683033:disease model [Intellectual Product]
   783   C0684309:Disease model [Experimental Model of Disease]
   753   C3161035:Model [Intellectual Product]
Processing 00000000.tx.283: Nature 404, 394-398.[CrossRef][Medline] Fujiwara, H., Hasegawa, M., Dohmae, N., Kawashima, A., Masliah, E., Goldberg, M. 

Phrase: "Nature 404,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "394-398."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fujiwara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "Dohmae,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Kawashima,"

Phrase: "A.,"

Phrase: "Masliah,"

Phrase: "E.,"

Phrase: "Goldberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.284: S., Shen, J., Takio, K. and Iwatsubo, T. 

Phrase: "S."

Phrase: ","

Phrase: "Shen,"

Phrase: "J.,"

Phrase: "Takio,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.285: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.286: Alpha-synuclein is phosphorylated in synucleinopathy lesions. 

Phrase: "Alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "phosphorylated in synucleinopathy lesions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0221198:lesions [Finding]
   737 E C1546698:Lesion [Intellectual Product]
Processing 00000000.tx.287: Nat. 

Phrase: "Nat."
Processing 00000000.tx.288: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.289: 4, 160-164.[Medline] Furukawa, K., Estus, S., Fu, W., Mark, R. 

Phrase: "4,"

Phrase: "160-164."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Furukawa,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Estus,"

Phrase: "S."

Phrase: ","

Phrase: "Fu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0016360:FU [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
  1000   C1424823:FU [Gene or Genome]

Phrase: "W.,"

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.290: J. and Mattson, M. 

Phrase: "J."

Phrase: "and"

Phrase: "Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.291: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.292: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.293: Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. 

Phrase: "Neuroprotective action of cycloheximide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441472:Action [Functional Concept]
   770   C3266814:Action [Activity]

Phrase: "involves"

Phrase: "induction of Bcl-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "antioxidant pathways."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathways [Molecular Function]
   861   C1705987:Pathways [Conceptual Entity]
Processing 00000000.tx.294: J. 

Phrase: "J."
Processing 00000000.tx.295: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.296: 136, 1137-1149.[Abstract/Free FullText] Gai, W. 

Phrase: "136,"

Phrase: "1137-1149."

Phrase: "[Abstract/Free FullText"

Phrase: "] Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W."
Processing 00000000.tx.297: P., Power, J. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Power,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032863:Power [Human-caused Phenomenon or Process]

Phrase: "J."
Processing 00000000.tx.298: H., Blumbergs, P. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Blumbergs,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.299: C. and Blessing, W. 

Phrase: "C."

Phrase: "and"

Phrase: "Blessing,"

Phrase: "W."
Processing 00000000.tx.300: W. 

Phrase: "W."
Processing 00000000.tx.301: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.302: Multiple-system atrophy: a new alpha-synuclein disease? 

Phrase: "Multiple-system atrophy"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0037019:Multiple System Atrophy [Disease or Syndrome]
  1000   C0393571:Multiple System Atrophy [Disease or Syndrome]
   827   C0333641:Atrophy [Pathologic Function]
   827   C0439064:Multiple [Quantitative Concept]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0151514:Atrophic [Disease or Syndrome]
   755 E C0205373:Systemic [Functional Concept]

Phrase: ":"

Phrase: "a new alpha-synuclein disease?"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.303: Lancet 352, 547-548.[Medline] George, J. 

Phrase: "Lancet 352,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0777169:Lancet [Medical Device]

Phrase: "547-548."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] George,"

Phrase: "J."
Processing 00000000.tx.304: M., Jin, H., Woods, W. 

Phrase: "M."

Phrase: ","

Phrase: "Jin,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "W."
Processing 00000000.tx.305: S. and Clayton, D. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "and"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.306: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.307: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.308: Characterization of a novel protein regulated during the critical period for song learning in the zebra finch. 

Phrase: "Characterization of a novel protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "regulated during the critical period"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0010339:Critical Period [Temporal Concept]
   760   C0439531:/period [Temporal Concept]
   760   C0851285:Regulated [Governmental or Regulatory Activity]
   760   C1511545:Critical [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]

Phrase: "for song learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "in the zebra finch."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0326833:Zebra finch [Bird]
   861   C0325174:Zebra [Mammal]
   861   C0326915:Finch [Bird]
Processing 00000000.tx.309: Neuron 15, 361-372.[Medline] Giasson, B. 

Phrase: "Neuron 15,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "361-372."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.310: I., Murray, I. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Murray,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.311: V., Trojanowski, J. 

Phrase: "V., Trojanowski,"

Phrase: "J."
Processing 00000000.tx.312: Q. and Lee, V. 

Phrase: "Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.313: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.314: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.315: A hydrophobic stretch of 12 amino acid residues in the middle of alpha-synuclein is essential for filament assembly. 

Phrase: "A hydrophobic stretch of 12 amino acid residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0600080:stretch [Therapeutic or Preventive Procedure]

Phrase: "in the middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: "of alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "is"

Phrase: "essential for filament assembly."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.316: J. 

Phrase: "J."
Processing 00000000.tx.317: Biol. 

Phrase: "Biol."
Processing 00000000.tx.318: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.319: 276, 2380-2386.[Abstract/Free FullText] Hamilton, R. 

Phrase: "276,"

Phrase: "2380-2386."

Phrase: "[Abstract/Free FullText"

Phrase: "] Hamilton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.320: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.321: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.322: Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. 

Phrase: "Lewy bodies in Alzheimer's disease"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   835   C0752347:bodies disease lewy [Disease or Syndrome]
   806   C0085200:Lewy Bodies [Cell Component]
   760   C0242821:bodies [Human]
   760   C1995017:Bodies [Cell Component]
   726 E C0460148:Body [Anatomical Structure]
   726 E C1268086:Body [Anatomical Structure]

Phrase: ":"

Phrase: "a neuropathological review of 145 cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0282443:Review [Intellectual Product]
   753   C1552617:Review [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "alpha-synuclein immunohistochemistry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021044:Immunohistochemistry [Laboratory Procedure]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
Processing 00000000.tx.323: Brain Pathol. 

Phrase: "Brain Pathol."
Processing 00000000.tx.324: 10, 378-384.[Medline] Hemsley, A., Arnheim, N., Toney, M. 

Phrase: "10,"

Phrase: "378-384."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hemsley,"

Phrase: "A.,"

Phrase: "Arnheim,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Toney,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.325: D., Cortopassi, G. and Galas, D. 

Phrase: "D."

Phrase: ","

Phrase: "Cortopassi,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."
Processing 00000000.tx.326: J. 

Phrase: "J."
Processing 00000000.tx.327: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.328: A simple method for site-directed mutagenesis using the polymerase chain reaction. 

Phrase: "A simple method for site-directed mutagenesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C1704536:Direct Method [Therapeutic or Preventive Procedure]
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polymerase chain reaction."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]
Processing 00000000.tx.329: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.330: 17, 6545-6551.[Abstract] Irizarry, M. 

Phrase: "17,"

Phrase: "6545-6551."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Irizarry,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.331: C., Growdon, W., Gomez-Isla, T., Newell, K., George, J. 

Phrase: "C., Growdon,"

Phrase: "W.,"

Phrase: "Gomez-Isla,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Newell,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.332: M., Clayton, D. 

Phrase: "M."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.333: F. and Hyman, B. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Hyman,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.334: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.335: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.336: Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. 

Phrase: "Nigral"

Phrase: "and"

Phrase: "cortical Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   983   C3548436:cortical Lewy body [Cell Component]
   901   C0085200:Lewy Bodies [Cell Component]
   827   C0242821:bodies [Human]
   827   C1995017:Bodies [Cell Component]
   793 E C0460148:Body [Anatomical Structure]
   793 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "dystrophic nigral neurites in Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C2674684:Dystrophic neurites [Finding]
   753   C0085103:Neurites [Cell Component]

Phrase: "and"

Phrase: "cortical Lewy body disease"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0752347:Lewy Body Disease, Cortical [Disease or Syndrome]
           Lewy Body Disease
   923   C3548436:cortical Lewy body [Cell Component]
   861   C0085200:Lewy Body [Cell Component]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
   729 E C1995017:Bodies [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "alpha-synuclein immunoreactivity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597879:immunoreactivity [Molecular Function]
   734   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
Processing 00000000.tx.337: J. 

Phrase: "J."
Processing 00000000.tx.338: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.339: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.340: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.341: 57, 334-337.[Medline] Iwanaga, K., Wakabayashi, K., Yoshimoto, M., Tomita, I., Satoh, H., Takashima, H., Satoh, A., Seto, M., Tsujihata, M. and Takahashi, H. 

Phrase: "57,"

Phrase: "334-337."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Iwanaga,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wakabayashi,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Yoshimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Tomita,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Satoh,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takashima,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Satoh,"

Phrase: "A.,"

Phrase: "Seto,"

Phrase: "M."

Phrase: ","

Phrase: "Tsujihata,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Takahashi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.342: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.343: Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. 

Phrase: "Lewy body-type degeneration in cardiac plexus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0011164:Degeneration [Pathologic Function]
   748   C1880269:Degeneration [Functional Concept]

Phrase: "in Parkinson's"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C1021144:Parkinsonia [Plant]

Phrase: "and"

Phrase: "incidental Lewy body diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   906   C0752347:Lewy Body Disease [Disease or Syndrome]
   812   C0012634:Diseases [Disease or Syndrome]
   741 E C1836721:MALS [Finding]
   741 E C3538764:MALS [Gene or Genome]
   741 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.344: Neurology 52, 1269-1271.[Abstract/Free FullText] Jensen, P. 

Phrase: "Neurology 52,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0027855:Neurology [Biomedical Occupation or Discipline]
   789 E C0205494:Neurologic [Qualitative Concept]
   789 E C2707261:Neurological [Clinical Attribute]
   768 E C0027763:Nervous System [Body System]
   768 E C0422837:NERVOUS SYSTEM [Finding]
   768 E C1269560:Nervous system [Body System]

Phrase: "1269-1271."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.345: H., Nielsen, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nielsen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.346: S., Jakes, R., Dotti, C. 

Phrase: "S."

Phrase: ","

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Dotti,"

Phrase: "C."
Processing 00000000.tx.347: G. and Goedert, M. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.348: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.349: Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation. 

Phrase: "Binding of alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to brain vesicles"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C0333262:VESICLES [Acquired Abnormality]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "is"

Phrase: "abolished by familial Parkinson's disease mutation."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0030567:Parkinson Disease [Disease or Syndrome]
   790   C1521736:Parkinson's Disease [Functional Concept]
   790   C2681933:PARKINSON DISEASE [Gene or Genome]
   783   C0277558:Familial disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0015576:familial [Family Group]
   753   C0026882:Mutation [Genetic Function]
   753   C0241888:Familial [Functional Concept]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   748 E C0344339:disease family [Finding]
Processing 00000000.tx.350: J. 

Phrase: "J."
Processing 00000000.tx.351: Biol. 

Phrase: "Biol."
Processing 00000000.tx.352: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.353: 273, 26292-26294.[Abstract/Free FullText] Jensen, P. 

Phrase: "273,"

Phrase: "26292-26294."

Phrase: "[Abstract/Free FullText"

Phrase: "] Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.354: H., Li, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J."
Processing 00000000.tx.355: Y., Dahlstrom, A. and Dotti, C. 

Phrase: "Y.,"

Phrase: "Dahlstrom,"

Phrase: "A."

Phrase: "and"

Phrase: "Dotti,"

Phrase: "C."
Processing 00000000.tx.356: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.357: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.358: Axonal transport of synucleins is mediated by all rate components. 

Phrase: "Axonal transport of synucleins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0004462:Axonal Transport [Cell Function]
   770   C0005528:Transport, NOS [Cell Function]
   770   C1317949:Transport [Manufactured Object]
   770   C3495449:transport [Medical Device]

Phrase: "is"

Phrase: "mediated by all rate components."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0449432:Components [Manufactured Object]
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]
   726 E C1705248:Component [Conceptual Entity]
Processing 00000000.tx.359: Eur. 

Phrase: "Eur."
Processing 00000000.tx.360: J. 

Phrase: "J."
Processing 00000000.tx.361: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.362: 11, 3369-3376.[CrossRef][Medline] Jo, E., Fuller, N., Rand, R. 

Phrase: "11,"

Phrase: "3369-3376."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022418:JO [Geographic Area]

Phrase: "E.,"

Phrase: "Fuller,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Rand,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555436:Rand [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.363: P., George-Hyslop, P. and Fraser, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "George-Hyslop,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.364: E. 

Phrase: "E."
Processing 00000000.tx.365: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.366: Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein. 

Phrase: "Defective membrane interactions of familial Parkinson's disease mutant A30P alpha-synuclein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.367: J. 

Phrase: "J."
Processing 00000000.tx.368: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.369: Biol. 

Phrase: "Biol."
Processing 00000000.tx.370: 315, 799-807.[CrossRef][Medline] Jung, C., Yabe, J. 

Phrase: "315,"

Phrase: "799-807."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jung,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Yabe,"

Phrase: "J."
Processing 00000000.tx.371: T. and Shea, T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Shea,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.372: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.373: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.374: C-terminal phosphorylation of the high molecular weight neurofilament subunit correlates with decreased neurofilament axonal transport velocity. 

Phrase: "C-terminal phosphorylation of the high molecular weight neurofilament subunit"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0031715:Phosphorylation [Molecular Function]
   739   C1158886:Phosphorylation [Molecular Function]

Phrase: "correlates with decreased neurofilament axonal transport velocity."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C0004462:Axonal Transport [Cell Function]
   748   C0005528:Transport, NOS [Cell Function]
   748   C0027834:Neurofilament [Cell Component]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0439830:Velocity [Quantitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1317949:Transport [Manufactured Object]
   748   C1547053:*Velocity [Quantitative Concept]
   748   C3495449:transport [Medical Device]
   714 E C0547047:Decrease [Quantitative Concept]
Processing 00000000.tx.375: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.376: 856, 12-19.[CrossRef][Medline] Kahle, P. 

Phrase: "856,"

Phrase: "12-19."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.377: J., Neumann, M., Ozmen, L., Muller, V., Jacobsen, H., Schindzielorz, A., Okochi, M., Leimer, U., van Der Putten, H., Probst, A. et al. 

Phrase: "J.,"

Phrase: "Neumann,"

Phrase: "M."

Phrase: ","

Phrase: "Ozmen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Muller,"

Phrase: "V.,"

Phrase: "Jacobsen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schindzielorz,"

Phrase: "A.,"

Phrase: "Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Leimer,"

Phrase: "U.,"

Phrase: "van Der Putten,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Probst,"

Phrase: "A. et al."
Processing 00000000.tx.378: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.379: Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha-synuclein in human and transgenic mouse brain. 

Phrase: "Subcellular localization of wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0475264:Localisation [Functional Concept]
   760   C1744691:localisation [Biologic Function]

Phrase: "and"

Phrase: "Parkinson's disease-associated mutant alpha-synuclein in human"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   789   C1311196:synuclein alpha, human [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0439095:Alpha [Intellectual Product]
   744   C2003941:Alpha [Intellectual Product]
   744   C2350010:Alpha [Qualitative Concept]

Phrase: "and"

Phrase: "transgenic mouse brain."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1521713:Mouse Brain [Tissue]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   734   C0025936:Mouse, Transgenic [Mammal]
Processing 00000000.tx.380: J. 

Phrase: "J."
Processing 00000000.tx.381: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.382: 20, 6365-6373.[Abstract/Free FullText] Kahle, P. 

Phrase: "20,"

Phrase: "6365-6373."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.383: J., Neumann, M., Ozmen, L., Muller, V., Jacobsen, H., Spooren, W., Fuss, B., Mallon, B., Macklin, W. 

Phrase: "J.,"

Phrase: "Neumann,"

Phrase: "M."

Phrase: ","

Phrase: "Ozmen,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Muller,"

Phrase: "V.,"

Phrase: "Jacobsen,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Spooren,"

Phrase: "W.,"

Phrase: "Fuss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C0022107:Fussiness [Finding]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Mallon,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Macklin,"

Phrase: "W."
Processing 00000000.tx.384: B., Fujiwara, H. et al. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "H. et al."
Processing 00000000.tx.385: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.386: Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. 

Phrase: "Hyperphosphorylation"

Phrase: "and"

Phrase: "insolubility of alpha-synuclein"

Phrase: "in transgenic mouse oligodendrocytes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1511446:Mouse Oligodendrocyte [Cell]
   827   C0028944:Oligodendrocytes [Cell]
   734   C0025936:Mouse, Transgenic [Mammal]
Processing 00000000.tx.387: EMBO Rep. 

Phrase: "EMBO Rep."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1744664:REP [Molecular Function]
Processing 00000000.tx.388: 3, 583-588.[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "583-588."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.389: T., Schols, L. and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.390: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.391: Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. 

Phrase: "Ala30Pro mutation in the gene encoding alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0596611:Gene Mutation [Genetic Function]
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.392: Nat. 

Phrase: "Nat."
Processing 00000000.tx.393: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.394: 18, 106-108.[Medline] Lee, M. 

Phrase: "18,"

Phrase: "106-108."

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.395: K., Stirling, W., Xu, Y., Xu, X., Qui, D., Mandir, A. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Stirling,"

Phrase: "W.,"

Phrase: "Xu,"

Phrase: "Y.,"

Phrase: "Xu,"

Phrase: "X.,"

Phrase: "Qui,"

Phrase: "D."

Phrase: ","

Phrase: "Mandir,"

Phrase: "A."
Processing 00000000.tx.396: S., Dawson, T. 

Phrase: "S."

Phrase: ","

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.397: M., Copeland, N. 

Phrase: "M."

Phrase: ","

Phrase: "Copeland,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.398: G., Jenkins, N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jenkins,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.399: A. and Price, D. 

Phrase: "A."

Phrase: "and"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."
Processing 00000000.tx.400: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.401: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.402: Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice. 

Phrase: "Human alpha-synuclein-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]

Phrase: "harboring"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0475311:Harbor [Manufactured Object]

Phrase: "familial Parkinson's disease-linked Ala-53 Thr mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0026882:Mutation [Genetic Function]
   793   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurodegenerative disease with alpha-synuclein aggregation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0524851:Neurodegenerative Disease [Disease or Syndrome]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: "in transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]
Processing 00000000.tx.403: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.404: Natl. 

Phrase: "Natl."
Processing 00000000.tx.405: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.406: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.407: USA 99, 8968-8973.[Abstract/Free FullText] Leger, J., Kempf, M., Lee, G. and Brandt, R. 

Phrase: "USA 99,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "8968-8973."

Phrase: "[Abstract/Free FullText"

Phrase: "] Leger,"

Phrase: "J.,"

Phrase: "Kempf,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Brandt,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.408: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.409: Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. 

Phrase: "Conversion of serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439836:Conversion [Functional Concept]

Phrase: "to aspartate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085845:Aspartate [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "imitates"

Phrase: "phosphorylation-induced changes in the structure"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "and"

Phrase: "function of microtubule-associated protein tau."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0815043:function protein [Amino Acid, Peptide, or Protein]
   783   C1292719:Associated function [Functional Concept]
   783   C1527118:Protein Function [Molecular Function]
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]
   716   C1446659:MICROTUBULE-ASSOCIATED PROTEIN TAU [Gene or Genome]
   716   C2700455:Microtubule-Associated Protein Tau [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.410: J. 

Phrase: "J."
Processing 00000000.tx.411: Biol. 

Phrase: "Biol."
Processing 00000000.tx.412: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.413: 272, 8441-8446.[Abstract/Free FullText] Lippa, C. 

Phrase: "272,"

Phrase: "8441-8446."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lippa,"

Phrase: "C."
Processing 00000000.tx.414: F., Fujiwara, H., Mann, D. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fujiwara,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mann,"

Phrase: "D."
Processing 00000000.tx.415: M., Giasson, B., Baba, M., Schmidt, M. 

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.416: L., Nee, L. 

Phrase: "L., Nee,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.417: E., O'Connell, B., Pollen, D. 

Phrase: "E.,"

Phrase: "O'Connell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."
Processing 00000000.tx.418: A., St George-Hyslop, P. et al. 

Phrase: "A.,"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P. et al."
Processing 00000000.tx.419: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.420: Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. 

Phrase: "Lewy bodies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0085200:Lewy Bodies [Cell Component]
   861   C0242821:bodies [Human]
   861   C1995017:Bodies [Cell Component]
   827 E C0460148:Body [Anatomical Structure]
   827 E C1268086:Body [Anatomical Structure]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "altered alpha-synuclein in brains of many familial Alzheimer's disease patients"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0439095:Alpha [Intellectual Product]
   738   C2003941:Alpha [Intellectual Product]
   738   C2350010:Alpha [Qualitative Concept]
   718   C1336547:Synuclein Family [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "with mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in presenilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "amyloid precursor protein genes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Genes [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.421: Am. 

Phrase: "Am."
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.424: 153, 1365-1370.[Abstract/Free FullText] Lo, B. 

Phrase: "153,"

Phrase: "1365-1370."

Phrase: "[Abstract/Free FullText"

Phrase: "] Lo,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.425: C., Ridet, J. 

Phrase: "C., Ridet,"

Phrase: "J."
Processing 00000000.tx.426: L., Schneider, B. 

Phrase: "L., Schneider,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.427: L., Deglon, N. and Aebischer, P. 

Phrase: "L., Deglon,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Aebischer,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.428: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.429: Alpha-synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. 

Phrase: "Alpha-synucleinopathy"

Phrase: "and"

Phrase: "selective dopaminergic neuron loss in a rat lentiviral-based model"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0598940:neuron loss [Finding]
   739   C1517945:Loss [Quantitative Concept]
   724 E C1850496:Neuronal loss [Finding]

Phrase: "of Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.430: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.431: Natl. 

Phrase: "Natl."
Processing 00000000.tx.432: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.433: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.434: USA 99, 10813-10818.[Abstract/Free FullText] Maroteaux, L., Campanelli, J. 

Phrase: "USA 99,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: "10813-10818."

Phrase: "[Abstract/Free FullText"

Phrase: "] Maroteaux,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Campanelli,"

Phrase: "J."
Processing 00000000.tx.435: T. and Scheller, R. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Scheller,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.436: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.437: (1988). 

Phrase: "(1988"

Phrase: ")."
Processing 00000000.tx.438: Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ":"

Phrase: "a neuron-specific protein"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0027882:Neuron [Cell]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0205369:Specific [Qualitative Concept]
   827   C1552740:specific [Intellectual Product]
   755 E C0521390:Neuronal [Immunologic Factor]

Phrase: "localized to the nucleus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0007610:Nucleus [Cell Component]
   770   C0392752:Localized [Spatial Concept]

Phrase: "and"

Phrase: "presynaptic nerve terminal."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   913   C0206181:Presynaptic Terminal [Cell Component]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0205088:Terminal [Temporal Concept]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]
Processing 00000000.tx.439: J. 

Phrase: "J."
Processing 00000000.tx.440: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.441: 8, 2804-2815.[Abstract] Masliah, E., Iwai, A., Mallory, M., Uda, K. and Saitoh, T. 

Phrase: "8,"

Phrase: "2804-2815."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Masliah,"

Phrase: "E.,"

Phrase: "Iwai,"

Phrase: "A.,"

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Uda,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Saitoh,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.442: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.443: Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease. 

Phrase: "Altered presynaptic protein NACP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0285890:NACP [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C1420276:NACP [Gene or Genome]
   812   C2983377:NACP [Gene or Genome]

Phrase: "is"

Phrase: "associated with plaque formation"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0011389:Plaque [Disease or Syndrome]
   770   C0220781:formation [Biologic Function]
   770   C0332461:Plaque [Finding]
   770   C0333463:plaque [Acquired Abnormality]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "and"

Phrase: "neurodegeneration in Alzheimer's disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.444: Am. 

Phrase: "Am."
Processing 00000000.tx.445: J. 

Phrase: "J."
Processing 00000000.tx.446: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.447: 148, 201-210.[Abstract] Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke, L. 

Phrase: "148,"

Phrase: "201-210."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Masliah,"

Phrase: "E.,"

Phrase: "Rockenstein,"

Phrase: "E.,"

Phrase: "Veinbergs,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Mallory,"

Phrase: "M."

Phrase: ","

Phrase: "Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Sagara,"

Phrase: "Y.,"

Phrase: "Sisk,"

Phrase: "A."

Phrase: "and"

Phrase: "Mucke,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.448: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.449: Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. 

Phrase: "Dopaminergic loss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1517945:Loss [Quantitative Concept]

Phrase: "and"

Phrase: "inclusion body formation in alpha-synuclein mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: ":"

Phrase: "implications for neurodegenerative disorders."
Processing 00000000.tx.450: Science 287, 1265-1269.[Abstract/Free FullText] Murphy, D. 

Phrase: "Science 287,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1265-1269."

Phrase: "[Abstract/Free FullText"

Phrase: "] Murphy,"

Phrase: "D."
Processing 00000000.tx.451: D., Rueter, S. 

Phrase: "D."

Phrase: ","

Phrase: "Rueter,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.452: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.453: Q. and Lee, V. 

Phrase: "Q."

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.454: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.455: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.456: Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons. 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "developmentally"

Phrase: "expressed"

Phrase: ","

Phrase: "and"

Phrase: "alpha-synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]

Phrase: "regulates"

Phrase: "the size of the presynaptic vesicular pool"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0456389:size [Spatial Concept]

Phrase: "in primary hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.457: J. 

Phrase: "J."
Processing 00000000.tx.458: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.459: 20, 3214-3220.[Abstract/Free FullText] Nakamura, T., Yamashita, H., Takahashi, T. and Nakamura, S. 

Phrase: "20,"

Phrase: "3214-3220."

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamashita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Nakamura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.460: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.461: Activated Fyn phosphorylates alpha-synuclein at tyrosine residue 125. 

Phrase: "Activated Fyn"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0812303:FYN [Gene or Genome]
   861   C1442788:FYN [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "phosphorylates"

Phrase: "alpha-synuclein at tyrosine residue 125."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0439095:Alpha [Intellectual Product]
   753   C2003941:Alpha [Intellectual Product]
   753   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.462: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.463: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.464: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.465: Commun. 

Phrase: "Commun."
Processing 00000000.tx.466: 280, 1085-1092.[CrossRef][Medline] Nakamura, T., Yamashita, H., Nagano, Y., Takahashi, T., Avraham, S., Avraham, H., Matsumoto, M. and Nakamura, S. 

Phrase: "280,"

Phrase: "1085-1092."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakamura,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Yamashita,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nagano,"

Phrase: "Y.,"

Phrase: "Takahashi,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Avraham,"

Phrase: "S."

Phrase: ","

Phrase: "Avraham,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Matsumoto,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Nakamura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.467: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.468: Activation of Pyk2/RAFTK induces tyrosine phosphorylation of alpha-synuclein via Src-family kinases. 

Phrase: "Activation of Pyk2/RAFTK"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "tyrosine phosphorylation of alpha-synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1519726:Tyrosine Phosphorylation [Molecular Function]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "via Src-family kinases."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0282625:src-Family Kinases [Amino Acid, Peptide, or Protein,Enzyme]
           src Kinases
   827   C0015576:Family [Family Group]
   827   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.469: FEBS Lett. 

Phrase: "FEBS Lett."
Processing 00000000.tx.470: 521, 190-194.[CrossRef][Medline] Negro, A., Brunati, A. 

Phrase: "521,"

Phrase: "190-194."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Negro,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005680:Negro [Population Group]

Phrase: "A.,"

Phrase: "Brunati,"

Phrase: "A."
Processing 00000000.tx.471: M., Donella-Deana, A., Massimino, M. 

Phrase: "M."

Phrase: ","

Phrase: "Donella-Deana,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2990640:Deana [Eukaryote]

Phrase: "A.,"

Phrase: "Massimino,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.472: L. and Pinna, L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Pinna,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0013453:Pinna [Body Part, Organ, or Organ Component]
  1000   C0928075:Pinna [Body Part, Organ, or Organ Component]
  1000   C1047272:Pinna [Eukaryote]
  1000   C1706219:Pinna [Body Part, Organ, or Organ Component]

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.473: A. 

Phrase: "A."
Processing 00000000.tx.474: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.475: Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. 

Phrase: "Multiple phosphorylation of alpha-synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031715:Phosphorylation [Molecular Function]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "by protein tyrosine kinase Syk"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1335892:PROTEIN-TYROSINE KINASE SYK [Gene or Genome]
   756   C0033681:Protein Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   708   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "eosin-induced aggregation."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332621:Aggregation [Functional Concept]
   827   C0439168:% aggregation [Quantitative Concept]
   755 E C0205418:Aggregate [Qualitative Concept]
Processing 00000000.tx.476: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.477: 16, 210-212.[Abstract/Free FullText] Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. 

Phrase: "16,"

Phrase: "210-212."

Phrase: "[Abstract/Free FullText"

Phrase: "] Okochi,"

Phrase: "M."

Phrase: ","

Phrase: "Walter,"

Phrase: "J.,"

Phrase: "Koyama,"

Phrase: "A.,"

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Iwatsubo,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Meijer,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Kahle,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.478: J. and Haass, C. 

Phrase: "J."

Phrase: "and"

Phrase: "Haass,"

Phrase: "C."
Processing 00000000.tx.479: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.480: Constitutive phosphorylation of the Parkinson's disease associated alpha-synuclein. 

Phrase: "Constitutive phosphorylation of the Parkinson's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031715:Phosphorylation [Molecular Function]
   753   C1158886:Phosphorylation [Molecular Function]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.481: J. 

Phrase: "J."
Processing 00000000.tx.482: Biol. 

Phrase: "Biol."
Processing 00000000.tx.483: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.484: 275, 390-397.[Abstract/Free FullText] Perez, R. 

Phrase: "275,"

Phrase: "390-397."

Phrase: "[Abstract/Free FullText"

Phrase: "] Perez,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.485: G., Waymire, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Waymire,"

Phrase: "J."
Processing 00000000.tx.486: C., Lin, E., Liu, J. 

Phrase: "C., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "E.,"

Phrase: "Liu,"

Phrase: "J."
Processing 00000000.tx.487: J., Guo, F. and Zigmond, M. 

Phrase: "J.,"

Phrase: "Guo,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Zigmond,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: J. 

Phrase: "J."
Processing 00000000.tx.489: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.490: A role for alpha-synuclein in the regulation of dopamine biosynthesis. 

Phrase: "A role for alpha-synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of dopamine biosynthesis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1154438:dopamine biosynthesis [Molecular Function]
   861   C0005572:biosynthesis [Functional Concept]
   861   C0220781:Biosynthesis [Biologic Function]
Processing 00000000.tx.491: J. 

Phrase: "J."
Processing 00000000.tx.492: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.493: 22, 3090-3099.[Abstract/Free FullText] Perrin, R. 

Phrase: "22,"

Phrase: "3090-3099."

Phrase: "[Abstract/Free FullText"

Phrase: "] Perrin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.494: J., Woods, W. 

Phrase: "J.,"

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "W."
Processing 00000000.tx.495: S., Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.496: F. and George, J. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.497: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.498: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.499: Interaction of human alpha-synuclein and Parkinson's disease variants with phospholipids. 

Phrase: "Interaction of human alpha-synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704675:Interaction [Functional Concept]

Phrase: "and"

Phrase: "Parkinson's disease variants with phospholipids."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:variants [Qualitative Concept]
Processing 00000000.tx.500: Structural analysis using site-directed mutagenesis. 

Phrase: "Structural analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "site-directed mutagenesis."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0079870:Mutagenesis, Site-Directed [Genetic Function]
   827   C0079866:Mutagenesis [Molecular Function]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]
   827   C3146302:Mutagenesis [Laboratory Procedure]
   793   C0439851:Direct [Qualitative Concept]
   793   C1947931:Direct [Qualitative Concept]
   755 E C0439755:Directions [Spatial Concept]
   755 E C0449738:Direction [Spatial Concept]
   711 E C1707761:Directionality [Functional Concept]
   711 E C3274524:Directionality [Functional Concept]
Processing 00000000.tx.501: J. 

Phrase: "J."
Processing 00000000.tx.502: Biol. 

Phrase: "Biol."
Processing 00000000.tx.503: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.504: 275, 34393-34398.[Abstract/Free FullText] Polymeropoulos, M. 

Phrase: "275,"

Phrase: "34393-34398."

Phrase: "[Abstract/Free FullText"

Phrase: "] Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.505: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.506: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R. et al. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R. et al."
Processing 00000000.tx.507: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.508: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. 

Phrase: "Mutation in the alpha-synuclein gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0015576:Families [Family Group]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "with Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.509: Science 276, 2045-2047.[Abstract/Free FullText] Pronin, A. 

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pronin,"

Phrase: "A."
Processing 00000000.tx.510: N., Morris, A. 

Phrase: "N., Morris,"

Phrase: "A."
Processing 00000000.tx.511: J., Surguchov, A. and Benovic, J. 

Phrase: "J.,"

Phrase: "Surguchov,"

Phrase: "A."

Phrase: "and"

Phrase: "Benovic,"

Phrase: "J."
Processing 00000000.tx.512: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.513: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.514: Synucleins are a novel class of substrates for G protein-coupled receptor kinases. 

Phrase: "Synucleins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "a novel class of substrates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456387:Class [Intellectual Product]
   760   C1705943:Class [Classification]

Phrase: "for G protein-coupled receptor kinases."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0872043:G-Protein-Coupled Receptor Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   937   C0682972:G Protein-Coupled Receptor [Amino Acid, Peptide, or Protein,Receptor]
   897   C0010536:G-Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   875   C0033640:Protein Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   853   C0597357:protein receptor [Amino Acid, Peptide, or Protein,Receptor]
           receptor
   840   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0031727:Kinases [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0439267:g% [Quantitative Concept]
   804   C1948027:Coupled [Functional Concept]
   771 E C0010222:couple [Family Group]
Processing 00000000.tx.515: J. 

Phrase: "J."
Processing 00000000.tx.516: Biol. 

Phrase: "Biol."
Processing 00000000.tx.517: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.518: 275, 26515-26522.[Abstract/Free FullText] Sommer, B., Barbieri, S., Hofele, K., Wiederhold, K., Probst, A., Mistl, C., Danner, S., Kauffmann, S., Spooren, W., Tolnay, M. et al. 

Phrase: "275,"

Phrase: "26515-26522."

Phrase: "[Abstract/Free FullText"

Phrase: "] Sommer,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Barbieri,"

Phrase: "S."

Phrase: ","

Phrase: "Hofele,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Wiederhold,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Probst,"

Phrase: "A.,"

Phrase: "Mistl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Danner,"

Phrase: "S."

Phrase: ","

Phrase: "Kauffmann,"

Phrase: "S."

Phrase: ","

Phrase: "Spooren,"

Phrase: "W.,"

Phrase: "Tolnay,"

Phrase: "M. et al."
Processing 00000000.tx.519: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.520: Mouse models of alpha-synucleinopathy and Lewy pathology. 

Phrase: "Mouse"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "models of alpha-synucleinopathy"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439095:Alpha [Intellectual Product]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]
   770   C3161035:Model [Intellectual Product]

Phrase: "and"

Phrase: "Lewy pathology."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0030664:Pathology [Biomedical Occupation or Discipline]
   861   C0205469:pathology [Functional Concept]
   861   C0677042:pathology [Pathologic Function]
   789 E C1521733:Pathologic [Functional Concept]
Processing 00000000.tx.521: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.522: Gerontol. 

Phrase: "Gerontol."
Processing 00000000.tx.523: 35, 1389-1403.[CrossRef][Medline] Spillantini, M. 

Phrase: "35,"

Phrase: "1389-1403."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.524: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: L., Lee, V. 

Phrase: "L., Lee,"

Phrase: "V."
Processing 00000000.tx.526: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.527: Q., Jakes, R. and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.528: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.529: Alpha-synuclein in Lewy bodies. 

Phrase: "Alpha-synuclein in Lewy bodies."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439095:Alpha [Intellectual Product]
   760   C2003941:Alpha [Intellectual Product]
   760   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.530: Nature 388, 839-840.[CrossRef][Medline] Spillantini, M. 

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.531: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.532: A., Jakes, R., Cairns, N. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Cairns,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.533: J., Lantos, P. 

Phrase: "J.,"

Phrase: "Lantos,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.534: L. and Goedert, M. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.535: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.536: Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. 

Phrase: "Filamentous alpha-synuclein inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1512693:Inclusion [Qualitative Concept]

Phrase: "link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "multiple system atrophy with Parkinson's disease"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0037019:Multiple System Atrophy [Disease or Syndrome]
   833   C0393571:Multiple System Atrophy [Disease or Syndrome]
   753   C0333641:Atrophy [Pathologic Function]
   753   C0439064:Multiple [Quantitative Concept]
   753   C0449913:System [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   748   C0442893:Systemic disease [Disease or Syndrome]

Phrase: "and"

Phrase: "dementia with Lewy bodies."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0752347:Dementia with Lewy bodies [Disease or Syndrome]
           dementia lewy bodies
   865 E C2697416:DEMENTIA, LEWY BODY [Gene or Genome]
   770   C0011265:dementia [Mental or Behavioral Dysfunction]
   770   C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.537: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.538: Lett. 

Phrase: "Lett."
Processing 00000000.tx.539: 251, 205-208.[CrossRef][Medline] Utton, M. 

Phrase: "251,"

Phrase: "205-208."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Utton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.540: A., Connell, J., Asuni, A. 

Phrase: "A.,"

Phrase: "Connell,"

Phrase: "J.,"

Phrase: "Asuni,"

Phrase: "A."
Processing 00000000.tx.541: A., van Slegtenhorst, M., Hutton, M., de Silva, R., Lees, A. 

Phrase: "A.,"

Phrase: "van Slegtenhorst,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "de Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lees,"

Phrase: "A."
Processing 00000000.tx.542: J., Miller, C. 

Phrase: "J.,"

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "C."
Processing 00000000.tx.543: C. and Anderton, B. 

Phrase: "C."

Phrase: "and"

Phrase: "Anderton,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.544: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.545: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.546: The slow axonal transport of the microtubule-associated protein tau and the transport rates of different isoforms and mutants in cultured neurons. 

Phrase: "The slow axonal transport of the microtubule-associated protein tau"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C0598956:slow axonal transport [Cell Function]
   760   C0004462:Axonal Transport [Cell Function]
   757   C0007292:Transport protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C0599895:protein transport [Cell Function]
   757   C1159772:Protein Transport [Cell Function]
   739   C0005528:Transport, NOS [Cell Function]
   739   C1317949:Transport [Manufactured Object]
   739   C3495449:transport [Medical Device]

Phrase: "and"

Phrase: "the transport rates of different isoforms"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0005528:Transport, NOS [Cell Function]
   753   C1317949:Transport [Manufactured Object]
   753   C3495449:transport [Medical Device]
   719   C0871208:Rate [Activity]
   719   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "mutants in cultured neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0596988:mutants [Cell or Molecular Dysfunction]
Processing 00000000.tx.547: J. 

Phrase: "J."
Processing 00000000.tx.548: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.549: 22, 6394-6400.[Abstract/Free FullText] Van der Putten, H., Wiederhold, K. 

Phrase: "22,"

Phrase: "6394-6400."

Phrase: "[Abstract/Free FullText"

Phrase: "] Van der Putten,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wiederhold,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.550: H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Probst,"

Phrase: "A.,"

Phrase: "Barbieri,"

Phrase: "S."

Phrase: ","

Phrase: "Mistl,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Danner,"

Phrase: "S."

Phrase: ","

Phrase: "Kauffmann,"

Phrase: "S."

Phrase: ","

Phrase: "Hofele,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Spooren,"

Phrase: "W."
Processing 00000000.tx.551: P., Ruegg, M. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Ruegg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.552: A. et al. 

Phrase: "A. et al."
Processing 00000000.tx.553: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.554: Neuropathology in mice expressing human alpha-synuclein. 

Phrase: "Neuropathology in mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   790   C1540677:neuropathology [Pathologic Function]
   790   C1555824:Neuropathology [Intellectual Product]

Phrase: "expressing"

Phrase: "human alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   901   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439095:Alpha [Intellectual Product]
   827   C2003941:Alpha [Intellectual Product]
   827   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.555: J. 

Phrase: "J."
Processing 00000000.tx.556: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.557: 20, 6021-6029.[Abstract/Free FullText] Wang, L., Ho, C. 

Phrase: "20,"

Phrase: "6021-6029."

Phrase: "[Abstract/Free FullText"

Phrase: "] Wang,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ho,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1832110:HO [Gene or Genome]

Phrase: "C."
Processing 00000000.tx.558: L., Sun, D., Liem, R. 

Phrase: "L., Sun,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0038817:Sun [Natural Phenomenon or Process]
   861   C0376223:Sun [Geographic Area]

Phrase: "D."

Phrase: ","

Phrase: "Liem,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: K. and Brown, A. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.560: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.561: Rapid movement of axonal neurofilaments interrupted by prolonged pauses. 

Phrase: "Rapid movement of axonal neurofilaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0026649:Movement [Organism Function]

Phrase: "interrupted by prolonged pauses."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0439590:Prolonged [Temporal Concept]
   770   C0443239:Interrupted [Qualitative Concept]
   770   C0488347:Pauses [Clinical Attribute]
   770   C0489607:Pauses [Temporal Concept]
   770   C1512900:Interrupted [Temporal Concept]
   737 E C1550026:Pause [Idea or Concept]
Processing 00000000.tx.562: Nat. 

Phrase: "Nat."
Processing 00000000.tx.563: Cell Biol. 

Phrase: "Cell Biol."
Processing 00000000.tx.564: 2, 137-141.[CrossRef][Medline] Wang, L. and Brown, A. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "137-141."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wang,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.565: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.566: Rapid movement of microtubules in axons. 

Phrase: "Rapid movement of microtubules"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0026649:Movement [Organism Function]

Phrase: "in axons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]
Processing 00000000.tx.567: Curr. 

Phrase: "Curr."
Processing 00000000.tx.568: Biol. 

Phrase: "Biol."
Processing 00000000.tx.569: 12, 1496-1501.[CrossRef][Medline] Wu, Y., Spencer, S. 

Phrase: "12,"

Phrase: "1496-1501."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Y.,"

Phrase: "Spencer,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.570: D. and Lasky, L. 

Phrase: "D."

Phrase: "and"

Phrase: "Lasky,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.571: A. 

Phrase: "A."
Processing 00000000.tx.572: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.573: Tyrosine phosphorylation regulates the SH3-mediated binding of the Wiskott-Aldrich syndrome protein to PSTPIP, a cytoskeletal-associated protein. 

Phrase: "Tyrosine phosphorylation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1519726:Tyrosine Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "regulates"

Phrase: "the SH3-mediated binding of the Wiskott-Aldrich syndrome protein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1420024:SH3 binding protein [Gene or Genome]
   757   C0033618:Protein Binding [Molecular Function]
   757   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]

Phrase: "to PSTPIP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419051:PSTPIP [Gene or Genome]

Phrase: "a cytoskeletal-associated protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0010852:Cytoskeletal protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   913   C1414120:cytoskeletal protein [Gene or Genome]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.574: J. 

Phrase: "J."
Processing 00000000.tx.575: Biol. 

Phrase: "Biol."
Processing 00000000.tx.576: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.577: 273, 5765-5770.[Abstract/Free FullText] Xia, Z., Dudek, H., Miranti, C. 

Phrase: "273,"

Phrase: "5765-5770."

Phrase: "[Abstract/Free FullText"

Phrase: "] Xia,"

Phrase: "Z.,"

Phrase: "Dudek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Miranti,"

Phrase: "C."
Processing 00000000.tx.578: K. and Greenberg, M. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Greenberg,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.579: E. 

Phrase: "E."
Processing 00000000.tx.580: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.581: Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. 

Phrase: "Calcium influx via the NMDA receptor"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "immediate early gene transcription by a MAP kinase/ERK-dependent mechanism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   775   C0013458:Early Gene Transcription [Genetic Function]
   756   C0040649:Gene Transcription [Genetic Function]
           Transcription
Processing 00000000.tx.582: J. 

Phrase: "J."
Processing 00000000.tx.583: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.584: 16, 5425-5436.[Abstract/Free FullText]

Phrase: "16,"

Phrase: "5425-5436."

Phrase: "[Abstract/Free FullText"

Phrase: "]"

